

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Cell plasticity in cancer cell populations | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/9-635/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/9-635" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Cell plasticity in cancer cell populations" />
    
            <meta name="og:title" content="F1000Research Article: Cell plasticity in cancer cell populations.">
            <meta name="og:description" content="Read the latest article version by Shensi Shen, Jean Clairambault, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="27365">
            <meta name="article-id" content="24803">
            <meta name="dc.title" content="Cell plasticity in cancer cell populations">
            <meta name="dc.description" content="In this review, we propose a recension of biological observations on plasticity in cancer cell populations and discuss theoretical considerations about their mechanisms.">
            <meta name="dc.subject" content="Plasticity, Cancer, Modelling">
            <meta name="dc.creator" content="Shen, Shensi">
            <meta name="dc.creator" content="Clairambault, Jean">
            <meta name="dc.date" content="2020/06/22">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.24803.1">
            <meta name="dc.source" content="F1000Research 2020 9:635">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Plasticity">
            <meta name="prism.keyword" content="Cancer">
            <meta name="prism.keyword" content="Modelling">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2020/06/22">
            <meta name="prism.volume" content="9">
            <meta name="prism.number" content="635">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.24803.1">
            <meta name="prism.url" content="https://f1000research.com/articles/9-635">
            <meta name="citation_title" content="Cell plasticity in cancer cell populations">
            <meta name="citation_abstract" content="In this review, we propose a recension of biological observations on plasticity in cancer cell populations and discuss theoretical considerations about their mechanisms.">
            <meta name="citation_description" content="In this review, we propose a recension of biological observations on plasticity in cancer cell populations and discuss theoretical considerations about their mechanisms.">
            <meta name="citation_keywords" content="Plasticity, Cancer, Modelling">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Shensi Shen">
            <meta name="citation_author_institution" content="Inserm U981, Institut Gustave Roussy, Universit&eacute; Paris-Saclay, Villejuif, France">
            <meta name="citation_author" content="Jean Clairambault">
            <meta name="citation_author_institution" content="Sorbonne Universit&eacute;, CNRS, Universit&eacute; de Paris, Laboratoire Jacques&shy;Louis Lions (LJLL), &amp; Inria Mamba team, Paris, France">
            <meta name="citation_publication_date" content="2020/06/22">
            <meta name="citation_volume" content="9">
            <meta name="citation_publication_number" content="635">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.24803.1">
            <meta name="citation_firstpage" content="635">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/9-635/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/9-635.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=27365 /> <input type=hidden id=articleId name=articleId value=24803 /> <input type=hidden id=xmlUrl value="/articles/9-635/v1/xml"/> <input type=hidden id=xmlFileName value="-9-635-v1.xml"> <input type=hidden id=article_uuid value=0521f1ca-5106-433e-968d-3ed0c230b29e /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Cell plasticity in cancer cell populations"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.24803.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.24803.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/9-635"
  },
  "headline": "Cell plasticity in cancer cell populations",
  "datePublished": "2020-06-22T16:07:13",
  "dateModified": "2020-06-22T16:07:13",
  "author": [
    {
      "@type": "Person",
      "name": "Shensi Shen"
    },    {
      "@type": "Person",
      "name": "Jean Clairambault"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "In this review, we propose a recension of biological observations on plasticity in cancer cell populations and discuss theoretical considerations about their mechanisms."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/9-635.html",
            "name": "Cell plasticity in cancer cell populations"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Cell plasticity in cancer cell populations </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=27365 data-id=24803 data-downloads="" data-views="" data-scholar="10.12688/f1000research.24803.1" data-recommended="" data-doi="10.12688/f1000research.24803.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/9-635/v1/pdf?article_uuid=0521f1ca-5106-433e-968d-3ed0c230b29e" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-24803-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-24803-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-24803-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Shen S and Clairambault J. Cell plasticity in cancer cell populations [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2020, <b>9</b>(F1000 Faculty Rev):635 (<a class=new-orange href="https://doi.org/10.12688/f1000research.24803.1" target=_blank>https://doi.org/10.12688/f1000research.24803.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-24803-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=24803 id=track-article-signin-24803 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/24803?target=/articles/9-635.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=27365 /> <input name=articleId type=hidden value=24803 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Cell plasticity in cancer cell populations</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Shensi Shen<a href="https://orcid.org/0000-0002-5087-8220" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-5087-8220</div><sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:jean.clairambault@inria.fr" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Jean Clairambault</span></a><a href="https://orcid.org/0000-0002-8336-9641" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-8336-9641</div><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Shensi Shen<a href="http://orcid.org/0000-0002-5087-8220" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-5087-8220</div><sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:jean.clairambault@inria.fr" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Jean Clairambault</span></a><a href="http://orcid.org/0000-0002-8336-9641" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-8336-9641</div><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 22 Jun 2020 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.24803.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Inserm U981, Institut Gustave Roussy, Universit&eacute; Paris-Saclay, Villejuif, France<br/> <sup>2</sup> Sorbonne Universit&eacute;, CNRS, Universit&eacute; de Paris, Laboratoire Jacques&shy;Louis Lions (LJLL), &amp; Inria Mamba team, Paris, France<br/> <p> <div class=margin-bottom> Shensi Shen <br/> <span>Roles: </span> Conceptualization, Investigation, Methodology, Project Administration, Writing – Original Draft Preparation </div> <div class=margin-bottom> Jean Clairambault <br/> <span>Roles: </span> Conceptualization, Investigation, Methodology, Project Administration, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=69838-65179></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=11564-65180></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> In this review, we propose a recension of biological observations on plasticity in cancer cell populations and discuss theoretical considerations about their mechanisms. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Plasticity, Cancer, Modelling </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Jean Clairambault (<a href="mailto:jean.clairambault@inria.fr">jean.clairambault@inria.fr</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Jean Clairambault </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This work was supported by The Association for Cancer Research (ARC) Foundation Project: No. PJA 20161204588 (to S. S). <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2020 Shen S and Clairambault J. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Shen S and Clairambault J. Cell plasticity in cancer cell populations [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2020, <b>9</b>(F1000 Faculty Rev):635 (<a href="https://doi.org/10.12688/f1000research.24803.1" target=_blank>https://doi.org/10.12688/f1000research.24803.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 22 Jun 2020, <b>9</b>(F1000 Faculty Rev):635 (<a href="https://doi.org/10.12688/f1000research.24803.1" target=_blank>https://doi.org/10.12688/f1000research.24803.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 22 Jun 2020, <b>9</b>(F1000 Faculty Rev):635 (<a href="https://doi.org/10.12688/f1000research.24803.1" target=_blank>https://doi.org/10.12688/f1000research.24803.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d3732e148>Introduction</h2><p class="" id=d3732e151>Phenotype switching – or, more generally, continuous phenotype-determined cell plasticity – is an essential process originally observed during development but now is also recognised as an important phenomenon upon injury and disease. In the context of anti-cancer therapies, cell plasticity enables tumour cells to change to a cell phenotypic identity that may be dependent (or not) on the drug target but without additional secondary genetic mutations. Indeed, the discovery of oncogenic-driven mutations favoured the development of diverse targeted therapies and showed unprecedented clinical response. Unfortunately, responses in general are incomplete and transient as resistances develop upon continuous treatment exposure. Along with well-known genetic alterations, cell plasticity has recently emerged as an unavoidable contributor to therapy evasion. Studying the underlying biological mechanisms of cell plasticity should not only enable a better understanding of cancer cell phenotypic and functional heterogeneity but also present novel opportunities to prevent the emergence of drug-refractory resistance. In this mini-review of recent research (focused on the years 2017–2020), we discuss adaptive behavioural phenomena in assumed genetically homogeneous cancer cell populations.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d3732e157>1. Challenging facts and possible mechanisms</h2><div class=section><a name=d3732e160 class=n-a></a><h3 class=section-title>1.1. Epithelial-to-mesenchymal transition in cancer</h3><p class="" id=d3732e165>In various cancers, tumour cells have been shown to hijack developmental processes to adapt to environmental stresses. One of the best described examples of phenotypic switching depends on the process of epithelial-to-mesenchymal transition (EMT). It consists of both morphological and molecular changes by loss of apical–basal polarity and epithelial cell junctions accompanied by down-regulation of E-cadherin expression and acquisition of mesenchymal properties, including expression of vimentin and fibroblast-like morphology (<a href="#f1">Figure 1A</a>, ‘EMT’). EMT is completely reversible insofar as carcinoma cells change their phenotypes without genetic mutations. In particular, tumour cells can occupy a hybrid phenotypic state characterised by a mix of epithelial and mesenchymal features (partial EMT) and can revert to an epithelial state through the process of mesenchymal-to-epithelial transition (MET) as soon as they encounter a new environment. Indeed, coupled feedback loops of engineered network motifs by synthetic biology were shown to be able to generate intermediate hybrid EMT states<sup><a href="#ref-1">1</a></sup>. It seems that such a partial EMT phenotype is adopted by tumour cells to migrate as clusters<sup><a href="#ref-2">2</a></sup>, which we will discuss in Section 1.4.</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/27365/7e7c100e-ff08-4193-9710-6e1022681175_figure1.gif"><img alt="7e7c100e-ff08-4193-9710-6e1022681175_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/27365/7e7c100e-ff08-4193-9710-6e1022681175_figure1.gif"></a><div class=caption><h3>Figure 1. Summary of cell plasticity models.</h3><p id=d3732e189>(<b>A</b>) Four scenarios of cell plasticity represent the current models and challenges. (<b>B–E</b>) Potential mechanisms of cell plasticity on different levels. (B) On the chromatin level, epigenetic regulators and DNA elements are shown to be involved in tumour cell tolerance to chemotherapy. (C) On the cellular level, intracellular signalling pathways sensing diverse environmental cues reprogram the transcriptional landscape, leading to adaptation to drug exposures. (D) On the microenvironmental level, inter-cellular communications build up a ‘safe haven’ by direct cell-to-cell interactions and by ‘quorum sensing’ mechanisms. (E) Psychological distress remotely controls tumour cell adaptation by secreting systemic neurotrophic factors. Ac, ; BDNF, Brain-derived neurotrophic factor; BRAF, Proto-Oncogene B-Raf; CAF, Cancer-associated fibroblast; CBP, CREB Binding Protein; EMT, Epithelial-to-Mesenchymal transition; FAK, Focal Adhesion Kinase; GR, Growth factor; HDAC, Histone deacetylases; HGF, Hepatocyte Growth Factor; IFNγ, Interferon gamma; KDM, Lysine demethylases; Me, Methylation; SETDB, SET Domain Bifurcated Histone Lysine Methyltransferase; SMAD, Mothers Against Decapentaplegic Homolog; TEAD, Transcriptional Enhancer Factor TEF; TGF-β, Transforming growth factor beta; TRPA1, Transient Receptor Potential Cation Channel Subfamily A Member 1; TSC22D3, Glucocorticoid-Induced Leucine Zipper Protein; YAP/TAZ, Yes Associated Protein/ Transcriptional Coactivator With PDZ-Binding Motif; ZEB1, Zinc Finger E-Box Binding Homeobox 1.</p></div></div><p class="" id=d3732e202>Apart from its well-known action in metastasis, EMT has been shown to be involved in drug resistance. A recent study showed that EMT was involved in resistance to the third-generation epithelial growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)<sup><a href="#ref-3">3</a></sup>. The underlying biological mechanism by which EMT confers chemoresistance remains to be fully demonstrated. Nevertheless, transforming growth factor beta (TGFβ), a well-known EMT inducer, has been shown to be involved in EMT-related chemoresistance in <i>BRAF</i>V600E-mutated melanoma<sup><a href="#ref-4">4</a></sup> and in a breast cancer model<sup><a href="#ref-5">5</a></sup>. These recent observations raise questions about the nature of the molecular determinants of EMT and of the associated local phenomena. Is EMT always totally reversible? To what extent is it related to the ‘plasticity’ of cancer cells?</p></div><div class=section><a name=d3732e221 class=n-a></a><h3 class=section-title>1.2. Transient drug-induced tolerance</h3><p class="" id=d3732e226>The biological mechanisms that induce cancer cell plasticity upon drug treatment remain to be fully established. Nonetheless, it seemingly involves a stepwise transition whereby tumour cells undergo a slow proliferating drug-tolerant state, called drug-tolerant persisters (DTPs), before further developing secondary mutational drug resistance (<a href="#f1">Figure 1A</a>, ‘Drug-induced tolerance’). Persisters were firstly described in bacteria upon antibiotic challenges<sup><a href="#ref-6">6</a></sup>. Similarly, a subpopulation of non-small cell lung cancer (NSCLC) cells engages in a reversible phenotypic change in which DTPs survive the initial onslaught of anti-cancer therapies<sup><a href="#ref-7">7</a></sup>. Similar phenomena were observed in glioblastoma and melanoma<sup><a href="#ref-8">8</a>–<a href="#ref-10">10</a></sup>.</p><p class="" id=d3732e247>The observations of DTPs are complemented by <i>in vivo</i> studies in a basal cell carcinoma (BCC) model<sup><a href="#ref-11">11</a></sup>. Drug removal led the BCC DTPs to switch to a proliferation state and sensitised them to vismodegib, a standard care of BCC<sup><a href="#ref-12">12</a></sup>. More recently, a single-cell study in a <i>BRAF</i>V600E-mutated melanoma showed ‘micro-heterogeneity’ amid DTPs<sup><a href="#ref-13">13</a></sup>. Indeed, that study defined four cellular states in the melanoma DTPs: starvation-like melanoma cell state (SMC), neural crest stem cell-like state (NCSC), invasive state, and pigmented state<sup><a href="#ref-13">13</a></sup>. Computational analysis suggested a transition from SMC to a bifurcation point at which DTPs can engage with diverse traits by transiting into either the NCSC or pigmented state. Peroxisome proliferator-activated receptor alpha (PPARα)-mediated fatty acid oxidation-related gene expression is likely the key transcriptional mechanism in the SMC state<sup><a href="#ref-14">14</a></sup>, whereas retinoid X receptor gamma (RXRγ) and melanocyte-inducing transcription factor (MITF) are likely responsible for the NCSC and pigmented state, respectively<sup><a href="#ref-13">13</a>,<a href="#ref-15">15</a></sup>. Taken together, these observations are compatible with the fact that a stepwise transition through a slow cycling DTP state represents a non-genetic mechanism of therapy evasion that is independent of the tumour type or treatment.</p><p class="" id=d3732e284>It is still not clear whether the DTPs are a pre-existing cell subpopulation or arise stochastically from dynamical fluctuation. A recent finding may favour the latter concept; Shaffer <i>et al.</i> showed that a rare population of melanoma cells transiently displayed high expression of tolerance-related genes, such as <i>AXL</i>, prior to drug exposure and is resistant to anti-BRAF treatment<sup><a href="#ref-16">16</a></sup>. This population of cells could give rise to drug-sensitive cells in a stochastic manner<sup><a href="#ref-16">16</a></sup>. These observations are reminiscent of gene expression noise due to randomness in transcription and translation. Fundamentally, the noisy expression of a gene originates from the discrete and inherently random biochemical reactions of low numbers of modules involved in the production of mRNAs and proteins, thus leading to non-genetic cell-to-cell variations. Cells rely on some combinations of variability in gene expression that could be beneficial in times of stress insults<sup><a href="#ref-17">17</a></sup>. In terms of drug resistance, a recent study showed that high expression noise of a positive-feedback network favoured adaptation under high concentration of drug exposure but that a low-noise, negative-feedback network maintained resistance by acquiring mutations<sup><a href="#ref-18">18</a></sup>. Note that such non-genetic mechanisms can also be represented in the non-stochastic, deterministic modelling framework of phenotype-structured differential equations by a diffusion term coding for non-genetic instability, standing for reversible epimutations<sup><a href="#ref-19">19</a></sup> (see also Section 3.5).</p></div><div class=section><a name=d3732e315 class=n-a></a><h3 class=section-title>1.3. Dedifferentiation and transdifferentiation</h3><p class="" id=d3732e320>Conversion of lineage has been extensively studied in the context of development. The well-known, mainly metaphoric, Waddington’s landscape has been proposed to illustrate the fact that a progenitor cell normally rolls down within epigenetic differentiation ‘valleys’ and, owing to phenotypic bifurcations, can develop into the various finally differentiated tissue types that constitute a coherent multicellular organism (see also Section 4). In the context of cancer, dedifferentiation and transdifferentiation were observed upon therapeutic challenges, which suggests a possible plasticity in ‘cancer’s Waddington landscape’, which has metaphorically flattened valleys and lowered epigenetic barriers.</p><p class="" id=d3732e323>In BCC, distinct compartments of the skin epithelium are maintained by different pools of residing stem cells, including interfollicular epidermis (IFE), bulge, isthmus and sebaceous gland. Upon activation of the Hedgehog oncogenic pathway, basal cells in the IFE are reprogrammed to a bulge-like cell state and thus initiate BCC<sup><a href="#ref-20">20</a></sup>. Upon inhibition of the Hedgehog pathway, some BCC cells can transdifferentiate towards a mixed isthmus and IFE cell feature<sup><a href="#ref-11">11</a></sup>. Similar transdifferentiation was observed in prostate cancer dependent on androgen receptor (AR)-mediated signalling. Histological analysis of castration-resistant prostate cancer showed a subtype of neuroendocrine transdifferentiation in an AR-independent manner<sup><a href="#ref-21">21</a>–<a href="#ref-23">23</a></sup>. Similarly, EGFR-driven NSCLC was observed to convert towards a small cell lung cancer (SCLC) phenotype upon EGFR inhibition, thus leading to therapy evasion<sup><a href="#ref-24">24</a>,<a href="#ref-25">25</a></sup>. In rare scenarios, EGFR-driven NSCLC can also transdifferentiate into neuroendocrine histology, including large cell neuroendocrine carcinoma and small or large cell carcinoma<sup><a href="#ref-26">26</a></sup>. Interestingly, even with a mixed SCLC and NSCLC phenotype, the transdifferentiated SCLC tumour retained their original EGFR mutation, indicating that they were not <i>de novo</i> tumours. The above observations support the idea that a tiny subpopulation, diverging from the predominant cell phenotype prior to targeted therapy, may be subjected to a combination of Lamarckian plasticity and Darwinian selection upon anti-cancer therapies (<a href="#f1">Figure 1A</a>, ‘Transdifferentiation’).</p><p class="" id=d3732e359>Independent of transdifferentiation processes, simple blockade of differentiation is a characteristic of acute myeloblastic leukaemias (AMLs)<sup><a href="#ref-27">27</a></sup>. In the case of AML3, blockade occurs at the promyelocytic stage, resulting in poorly differentiated myeloblasts invading the bone marrow and later the blood of patients. Such blockade is due to the chimeric protein PML-RARα, which can be inhibited by all-trans retinoic acid (ATRA)<sup><a href="#ref-28">28</a></sup>. However, this success story in redifferentiation therapy is totally dependent on the existence of the fusion gene PML-RARα and the inhibition of the resulting chimeric protein by an adequate molecule, a situation that unfortunately has not been shown to be transposable to other cases of AML.</p></div><div class=section><a name=d3732e371 class=n-a></a><h3 class=section-title>1.4. Transient spatial organisation</h3><p class="" id=d3732e376>By functioning as an entity, collective migration provides the active and passive translocation of mobile and non-mobile cells. Such a collective cell migration may reveal worse clinical outcomes than single cells (<a href="#f1">Figure 1A</a>, ‘Spatial organisation’).</p><p class="" id=d3732e382>A recent study showed that colorectal tumour dissemination contained large clusters of epithelial cells displaying a robust outward apical pole, termed ‘tumour spheres with inverted polarity’, which propagate through the collective apical budding of colorectal cancer downstream of TGFβ signalling<sup><a href="#ref-29">29</a></sup>. This is in opposition to the traditional idea that the loss of apico-basolateral polarity is associated with the dissemination of carcinomas, suggesting that the collective tumour cell plasticity may not require the EMT program. Collective cell plasticity was also observed in breast cancer cell dissemination. However, collective cell invasion is often limited because breast cancer cells can only move through the paths structured by fibroblasts. Therefore, tumour cells may hijack the stromal fibroblasts to be the leader cells by remodelling the extracellular matrix<sup><a href="#ref-30">30</a></sup>. Similarly, during early stages of lung adenocarcinoma metastasis, these cancer cells experience an epithelial-like collective invasion and are surrounded by vimentin-positive cancer-associated fibroblasts<sup><a href="#ref-31">31</a>,<a href="#ref-32">32</a></sup>, which could also be adapted by an intermediate partial EMT program<sup><a href="#ref-2">2</a></sup>, thus further strengthening the idea that cooperation between cancer cells and normal fibroblasts can contribute to tumour collective migration and worse clinical outcome.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d3732e408>2. What is plasticity in cancer?</h2><div class=section><a name=d3732e411 class=n-a></a><h3 class=section-title>2.1. Possible definitions of plasticity</h3><p class="" id=d3732e416>Cell plasticity is the ability of cells to change their phenotypes without genetic mutations in response to environmental cues. Pathological conditions, particularly neoplasms, have been associated with increased plasticity. For instance, Barrett’s oesophagus, a pre-malignant precursor of oesophageal adenocarcinoma, has been proposed to be such a manifestation of plasticity since it consists of the conversion of the normal squamous lining (multilayer) of the oesophagus into an intestinal-like columnar (monolayer) epithelium. Stem cells have also displayed greater plasticity when they are not within their residing tissues, leading to the proposition that the origin of cancer resides in pluripotent stem cells. However, the existence of cancer stem cells (CSCs) may not be the only way that cancer cells acquire their known plasticity. Indeed, the atavistic theory of cancer (see also Section 4.4) proposes another process through which they reach such plasticity. Epigenetic instability followed by genetic instability<sup><a href="#ref-33">33</a></sup> in the tumour microenvironment may explain such plasticity without resorting to CSCs.</p><p class="" id=d3732e423>Open questions that arise are the following: Is plasticity a feature of cancer cell populations with binary phenotypic switch or with continuous changes (or both)? Is reversibility a common feature of cancer cell plasticity? It should be noted that from a continuous modelling point of view, the former concept allows us to deal with compartmental ordinary differential equations (ODEs) (<a href="#f2">Figure 2A</a>), whereas the latter implies phenotype-structured partial differential equations (PDEs) yielding completely continuous and reversible spectra of heterogeneity within the cell populations, which we will briefly develop in this review, about drug delivery optimisation in cancer cell populations. From a discrete and stochastic modelling point of view, agent-based models (ABMs) (<a href="#f2">Figure 2B</a>) certainly may also be used and indeed they often offer a way to justify PDE models by passing to the limit in number (N -&gt;∞) and size (ε -&gt;0) of cells. We firstly examine biological observations of phenotypic plasticity at different levels of multicellular organisms.</p><a name=f2 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/27365/7e7c100e-ff08-4193-9710-6e1022681175_figure2.gif"><img alt="7e7c100e-ff08-4193-9710-6e1022681175_figure2.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/27365/7e7c100e-ff08-4193-9710-6e1022681175_figure2.gif"></a><div class=caption><h3>Figure 2. Referenced mathematical models of cell populations take cell plasticity into account by making use of ordinary differential equations (A), agent-based models (B) and phenotype-structured partial differential equations (C–F).</h3><p id=d3732e442>Here, we present only the dynamics, not the initial or the boundary conditions, of the models. These models are chosen to be simple on purpose since they are all meant to provide a theoretical framework for therapeutic control and its optimisation. In particular, we do not present large systems of ordinary differential equations or large molecular networks, which nonetheless are referenced in the text. DTEP, Drug tolerant expanded persister; DTP, Drug tolerant persister; HSC, Hematopoetic stem cell; LSC, Leukemic stem cell; R, Resistant cell; S, Sensitive cell.</p></div></div></div><div class=section><a name=d3732e450 class=n-a></a><h3 class=section-title>2.2. Chromatin level</h3><p class="" id=d3732e455>The reversible feature of the cell plasticity that is triggered upon drug exposure, points towards a key role for transcriptional regulation at both an epigenetic level and a transcription factor level (<a href="#f1">Figure 1B</a>). One of the most studied epigenetic regulations in cancer cell plasticity might be histone lysine demethylase 5 (KDM5). KDM5A leads to reduced trimethylation of histone 3 lysine 4 (H3K4me3) and forms a physical interaction complex with histone deacetylase (HDAC). Sharma <i>et al.</i><sup><a href="#ref-7">7</a></sup> found that after treatment with an HDAC inhibitor or direct inhibition of KDM5A<sup><a href="#ref-34">34</a></sup>, DTPs restored their sensitivity to EGFR inhibition. Another KDM5 family protein, KDM5B, may bind to the promoters of cyclin-dependent kinase inhibitors (that is, p16, p21 and p27 and so on) and inhibit the transcription of these factors through demethylating the promoter-associated H3K4me3, thus leading to residual melanoma DTPs entering into a quiescent state<sup><a href="#ref-35">35</a></sup>. In addition, another histone demethylase family protein, KDM6A/B, plays a key role in glioblastoma stem cell (GSC) plasticity, in which tolerant GSCs up-regulate KDM6A/B and redistribute histone H3 lysine 27 trimethylation (H3K27me3) on repressive chromatins<sup><a href="#ref-8">8</a></sup>.</p><p class="" id=d3732e479>The epigenetic repression via modification of histone methylations may have considerable consequences for the activity of transposable elements. A recent study showed that H3K9me3-mediated repression of long interspersed repeat element 1 (LINE-1) was involved in the transient survival of NSCLC DTPs<sup><a href="#ref-36">36</a></sup>. In keeping with this, the authors found an accompanying up-regulation of H3K9me3-specific histone methyltransferases SETDB1 and SETDB2 in the same population, enlarging the possible role of other epigenetic factors.</p><p class="" id=d3732e486>Given that SETDB1 and SETDB2 are known interferon (IFN)-stimulated genes, an enrichment of IFN pathway activation was observed in NSCLC and melanoma DTPs<sup><a href="#ref-37">37</a>,<a href="#ref-38">38</a></sup>, establishing a link between methyltransferase and IFN signalling for drug-induced cell plasticity. Nevertheless, this link likely extends to adaptive resistance to immune checkpoint blockade. Benci <i>et al.</i> recently reported that prolonged IFN signalling in melanoma promotes epigenetic remodelling via transcriptional regulation of multiple T-cell inhibitory receptors, thus leading to resistance to anti-PD1 immunotherapy<sup><a href="#ref-39">39</a></sup>. An assay for transposase-accessible chromatin using sequencing (ATAC-seq) of melanoma cells showed about 50% of open chromatin regions with high STAT1 occupancy. This suggests that a consequence of this immunotherapy-induced epigenetic remodelling was to enrich IFN signalling that was also observed in NSCLC DTPs<sup><a href="#ref-36">36</a></sup>.</p><p class="" id=d3732e507>Adaptive mutability has also been reported in cancer DTPs. An adaptive shift towards the induction of error-prone DNA polymerases, such as Polκ and Rev1, leads to base mispairings, incorporation of aberrant DNA primer ends and thus increased mutagenesis rate<sup><a href="#ref-40">40</a></sup>. Of note, genome-wide 5-methylcytosine (5meC) hypomethylation frequently occurs in cancer genomes, leading to widespread genomic instability and de-repression of repetitive elements such as transposable elements. It is thought that hydrolytic deamination of 5meC to thymine results in T:G mismatch, which is more difficult to repair<sup><a href="#ref-33">33</a>,<a href="#ref-41">41</a></sup>. Therefore, it is plausible to hypothesise that DNA 5meC methyltransferase regulation and suppression of DNA repair gene expression cooperate to promote the development of drug resistance. However, whether a high 5meC level is associated with adaptive mutability observed in cancer DTPs still needs further exploration. Inasmuch as the regulations at the chromatin level are of an enzymatic nature with continuous activity depending on the environmental substrates, it may leave completely open the question (in Section 2.1) of plasticity as a switch-like or a continuous change of phenotypes.</p></div><div class=section><a name=d3732e522 class=n-a></a><h3 class=section-title>2.3. Cell level: intracellular regulatory pathways</h3><p class="" id=d3732e527>Chromatin level changes are generally induced by intracellular signalling cues (<a href="#f1">Figure 1C</a>), in which coordinated signalling networks define a specific cellular state<sup><a href="#ref-42">42</a></sup>. In the context of EMT, TGFβ induces the transcription factors Snail, Slug and ZEB1, which are each implicated in mediating the effects of TGFβ at least in part through the repression of E-cadherin. A double-negative feedback loop was observed in the TGFβ-mediated signalling response. ZEB1 expression inhibits the induction of microRNA miR-200, whereas a high level of miR-200 can inhibit the transcriptional activity of ZEB1. The TGFβ-ZEB/miR-200 double-negative feedback loop has been postulated to explain both the stability and interchangeability of epithelial versus mesenchymal phenotypes, in which mathematical modelling and experimental validation demonstrated that hysteresis control of EMT is dependent on the miR-200/ZEB1 double-negative feedback loop<sup><a href="#ref-43">43</a></sup>. Although it may not be responding directly to TGFβ, another important factor, Twist, links EMT to the ability of breast cancer cells to enter the circulation and seed metastases<sup><a href="#ref-44">44</a>,<a href="#ref-45">45</a></sup>. The mutually repressing mechanism was also seen at the network level; for instance, the BACH1 network reveals the existence of an inverse relationship between BACH1 and Raf kinase inhibitory protein (RKIP) involving both monostable and bistable transitions that potentially give rise to non-genetic variability<sup><a href="#ref-46">46</a></sup>.</p><p class="" id=d3732e552>The mesenchymal phenotype was also shown to be accompanied by AXL up-regulation both in NSCLC and in melanoma DTPs<sup><a href="#ref-16">16</a></sup>. Activation of AXL was associated with EMT features in erlotinib-resistant tumours and occurred either through its overexpression or via up-regulation of autocrine growth arrest-specific gene 6 (GAS6). AXL was identified as part of a gene set regulated by the transcription cofactors YAP1 and TAZ. These factors interact with TEAD1–4 transcription factors and are recruited to the <i>AXL</i> gene promoter via four TEAD-binding elements. Interestingly, a recent study showed that alternative activation of the Hippo pathway upon treatment by EGFR inhibitors in NSCLC promoted a strong epigenetic alteration driven by YAP/TEAD<sup><a href="#ref-47">47</a></sup>. Further dissection of the regulation of the YAP/TAZ/TEAD-AXL pathway will be needed at the single-cell level to examine the interactions with other signalling factors.</p><p class="" id=d3732e566>Apart from the well-defined EMT pathways, other intracellular signalling pathways are involved in drug-induced cell plasticity. Moparthi <i>et al.</i> showed that a FOXB2–WNT7B signalling axis induced prostate cancer transdifferentiation into neuroendocrine cell types via increased TCF/LEF-dependent transcription without activating the WNT co-receptor LRP6 or β-catenin<sup><a href="#ref-48">48</a></sup>. Intracellular signals can also be relayed through post-transcriptional modifications of mRNAs. A recent study showed that mRNA N6-methyladenosine (m6A) modification was involved in reversible resistance to BCR/ABL inhibitors in leukaemia<sup><a href="#ref-49">49</a></sup>. This is consistent with another study in melanoma DTPs<sup><a href="#ref-9">9</a></sup>. A subpopulation of m6A-associated mRNAs in their 5′ untranslated regions is up-regulated at the translational level upon BRAF inhibitor exposure<sup><a href="#ref-9">9</a></sup>. The m6A methylation is associated with mRNA stability or protein synthesis. Thus, the alternative m6A modification in DTPs may lead to a novel mRNA translation landscape. In keeping with this, Baskar <i>et al.</i> showed that mRNA translation was involved in non-heritable resistance to apoptosis induced by tumour necrosis factor alpha (TNFα)-related apoptosis-inducing ligand (TRAIL)<sup><a href="#ref-50">50</a></sup>.</p></div><div class=section><a name=d3732e597 class=n-a></a><h3 class=section-title>2.4. Microenvironmental level: tumour–stroma interactions</h3><p class="" id=d3732e602>Solid tumours are comprised of tumour cells and stromal cells, including fibroblasts, endothelial cells and infiltrated immune cells. Together with embedded extracellular matrix and vascularisation, the tumour microenvironment is involved not only in tumour growth but also in therapy-induced plasticity (<a href="#f1">Figure 1D</a>).</p><p class="" id=d3732e608>Cancer-associated fibroblasts (CAFs) are among the most well-documented cell populations in promoting therapy resistance. In melanoma, <i>BRAF</i> inhibition induces a paradoxical activation of the MAPK/ERK pathway in <i>BRAF</i> wild-type melanoma-associated fibroblasts. These cells in turn lead to elevated integrin β1-FAK-Src activation in melanoma cells undergoing treatment, generating a drug-tolerant microenvironment that provides a ‘safe haven’ for melanoma cells<sup><a href="#ref-51">51</a></sup>. Apart from direct cell-to-cell contact, CAF-secreted hepatocyte growth factor (HGF) binds to c-MET receptor on breast cancer cells, leading to alternative activation of the PI3K/AKT signalling pathway and attenuation of HER2 inhibitor sensitivity in basal-like breast cancer cells<sup><a href="#ref-52">52</a>,<a href="#ref-53">53</a></sup>. HGF/c-MET signalling is likely also involved in adaptive tolerance to cancer immunotherapy. Glodde <i>et al.</i> showed that, in the presence of HGF, neutrophils were recruited to the T cell–inflamed tumour microenvironment in response to cytotoxic immunotherapies and subsequently restrained T-cell expansion and cytotoxic T-cell effector functions<sup><a href="#ref-54">54</a></sup>.</p><p class="" id=d3732e636>As one of the largest stromal populations, tumour-associated macrophages (TAMs), co-evolving with tumour cells, are involved in tumour cell progression and impact on therapeutic responses. Prolonged interaction with M1-like TAMs can foster a chronic inflammation microenvironment, hence promoting cancer cell genomic instability<sup><a href="#ref-55">55</a></sup>. In this context, cancer cells acquire the ability to re-educate TAMs towards an anti-inflammatory M2-like state, which releases growth factors, pro-angiogenic molecules and immunosuppressive factors<sup><a href="#ref-56">56</a></sup>. Cancer cells and TAMs co-exist in the context of a complex, bidirectional metabolic relationship that not only is dictated by but also impinges on the tumour microenvironment<sup><a href="#ref-57">57</a></sup>. The release of CSF1, interleukin 34 (IL34) and VEGFA from tumour cells is particularly sensitive to chemotherapeutic stress, which is relevant to the metabolic symbiosis between hypoxic and normoxic cancer cells<sup><a href="#ref-58">58</a></sup>, and to the ability of lactate-producing cancer cells to repolarise TAMs towards an OXPHOS-dependent M2-like state<sup><a href="#ref-59">59</a></sup>. In melanoma, polarisation of M2-like TAMs is likely mediated by a mechanism involving a G protein–coupled receptor (GPCR) that senses microenvironmental acidosis<sup><a href="#ref-60">60</a></sup>. Importantly, the influence of cancer cells on TAMs is not unidirectional. Polarised TAMs secrete multiple cytokines with metabolic functions, including IL6, TNF, C-C motif chemokine ligand 5 (CCL5) and CCL18. Released IL6 favours tumour cell glycolysis by increasing the activity of 3-phosphoinositide-dependent protein kinase 1 (PDPK1)<sup><a href="#ref-61">61</a></sup>. It was shown that, along with cytokines, TAMs also release hypoxia-inducible factor 1 subunit-alpha (HIF1α)-stabilising long non-coding RNAs to promote the activity of HIF1α in neoplastic cells<sup><a href="#ref-62">62</a></sup>. Moreover, TAMs secrete a spectrum of pyrimidine species, such as deoxycytidine, into the microenvironment, which is taken up by tumour cells. Owing to chemical similarity, deoxycytidine taken up by tumour cells competes with gemcitabine for deoxycytidine kinase (DCK), thereby reducing its therapeutic efficacy<sup><a href="#ref-63">63</a></sup>.</p></div><div class=section><a name=d3732e678 class=n-a></a><h3 class=section-title>2.5. Systemic level: neuronal factors</h3><p class="" id=d3732e683>Among patients with cancer, emotional distress and psychiatric syndromes are prevalent during the whole period of the treatment, leading to system-level secretion of neuroendocrine hormones and neurotransmitters that could modify the tumour microenvironment and host macroenvironment<sup><a href="#ref-64">64</a>,<a href="#ref-65">65</a></sup> (<a href="#f1">Figure 1E</a>). Stress sensor TRPA1, a neuronal redox-sensing Ca<sup>2+</sup>-influx channel, was shown to mediate Ca<sup>2+</sup>-dependent anti-apoptotic pathways and protect cancer cells against chemotherapy, suggesting that cancer cells are capable of tolerating chemotherapy-induced oxidative stress by transmitting a pain signal<sup><a href="#ref-66">66</a></sup>. This system-level control of tumour adaptive response to anti-cancer treatment has also been reported in targeted therapies. The crosstalk between β2-AR induced by catecholamines and mutant EGFR results in the expression of IL6, which can further activate STAT3 signalling to render NSCLC cells tolerant to EGFR inhibitors<sup><a href="#ref-67">67</a></sup>. Other neurotrophic factors have also been shown to be involved in the survival and stemness of glioblastoma cells. For example, the brain-derived neurotrophic factor (BDNF) secreted by differentiated glioma cells activates the neurotrophic receptor kinase 2 (NTRK2) expressed on GSCs, which promotes the activation of AKT pathways in the process of survival of GSCs<sup><a href="#ref-68">68</a></sup>. In addition to having an impact on drug treatment, psychological distress was recently shown to influence anti-tumour immunity. Yang <i>et al.</i> found that stress-elevated plasma corticosterone induced the expression of glucocorticoid-inducible factor TSC22D3 at the system level. TSC22D3 blocks type I IFN response in dendritic cells and thus abrogates IFNγ<sup>+</sup> T-cell activation in the tumour microenvironment<sup><a href="#ref-69">69</a></sup>. These results indicate that stress-induced glucocorticoid surge can subvert therapy-induced anti-cancer immunosurveillance.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d3732e729>3. Cancer cell plasticity in therapeutics</h2><p class="" id=d3732e732>Given the emerging role of cancer cell plasticity in drug tolerance and resistance, the development of strategies targeting the underlying mechanisms of plasticity may lead to durable responses. Different strategies could be proposed by direct inhibition of cell plasticity, direct elimination of DTPs or reversing the differentiation process. Most of the strategies undergoing exploration are studied in <i>in vitro</i> models, which will necessitate a complementary <i>in vivo</i> investigation. In addition, given the toxic side effects of combination strategies, therapeutic timing and dosing issues need to be taken into serious consideration.</p><div class=section><a name=d3732e741 class=n-a></a><h3 class=section-title>3.1. Direct inhibition of cell plasticity</h3><p class="" id=d3732e746>Combination treatments that prevent phenotypic switching could result in a further decrease of the residual tolerant cells, thus representing an attractive strategy. At the chromatin level, given the de-repression of LINE-1 elements, the combination of erlotinib with trichostatin A or entinostat, specific inhibitors of HDAC, was shown to prevent phenotypic switching towards DTPs in subsequent studies<sup><a href="#ref-36">36</a></sup>. In glioblastoma, the combination of dasatinib with KDM6 inhibitor (GSK-J4) was shown to impair a persister cell population<sup><a href="#ref-8">8</a></sup>. Apart from epigenetic modulation, CDK7 inhibitor THZ1, which represses RNA polymerase II–mediated transcription, was shown to synergise with targeted therapies to prevent DTPs<sup><a href="#ref-70">70</a></sup>.</p><p class="" id=d3732e761>At the intracellular pathway level, the combination of siltuximab (an IL6 monoclonal inhibitory antibody) and ruxolitinib (a JAK/STAT inhibitor) was reported to inhibit the emergence of a neuroendocrine phenotype in human prostate cancer cells<sup><a href="#ref-71">71</a></sup>. In BCC, combination treatment of vismodegib and WNT inhibition with LGK-974 showed a reduced residual tumour cell population<sup><a href="#ref-12">12</a></sup>.</p><p class="" id=d3732e772>In addition to direct inhibition of tumour cell proteins, targeting components at the microenvironmental level is likely also an alternative strategy to prevent cell plasticity. Given the importance of HGF in modulating cell plasticity, combination treatment of crizotinib (c-MET inhibitor) and BRAF inhibitors suppressed CAF-mediated tolerance in melanoma<sup><a href="#ref-72">72</a></sup>. In basal-like breast tumours, treatment of PDGF-CC inhibitory antibody 6B3 can suppress the crosstalk between CAF and breast tumour cells, thus preventing transdifferentiation induced by tamoxifen or letrozole<sup><a href="#ref-73">73</a></sup>.</p></div><div class=section><a name=d3732e784 class=n-a></a><h3 class=section-title>3.2. Direct elimination of drug-tolerant cells</h3><p class="" id=d3732e789>Direct targeting DTPs in combination with chemotherapies can achieve the aim of killing sensitive and tolerant cells at the same time. Treatment with AXL antibody–drug conjugate has been shown to eliminate AXL-expressing melanoma DTPs, leading to inhibition of tumour growth in melanoma patient–derived xenografts<sup><a href="#ref-74">74</a></sup>. Shen <i>et al.</i> also showed that targeting translation initiation factor eIF4A with silvestrol could specifically eliminate melanoma DTPs<sup><a href="#ref-9">9</a></sup>. Metabolic targeting of the phospholipid glutathione peroxidase 4 (GPX4) with RSL3 was shown to induce ferroptosis of DTPs in multiple cancer models<sup><a href="#ref-75">75</a>–<a href="#ref-77">77</a></sup>. Rambow <i>et al.</i> showed that targeting RXRγ with HX531 could specifically eliminate NCSC DTPs<sup><a href="#ref-13">13</a></sup>. However, this single-cell study raises the concern that targeting a specific component may not suffice to eliminate all DTPs because it is not possible to target multi-stage DTPs simultaneously.</p></div><div class=section><a name=d3732e819 class=n-a></a><h3 class=section-title>3.3. Reversal to the differentiation process</h3><p class="" id=d3732e824>The most straightforward strategy is the ‘drug holiday’ due to the reversibility of the DTPs. Intermittent on-and-off dosing schedules have been shown to double the time of response of melanoma cells to BRAF inhibition<sup><a href="#ref-78">78</a></sup>. However, the length of the drug holidays is still difficult to determine from the clinical point of view, where patient care would be extremely complicated because of the unexpected explosive proliferation of the tumour. In addition, this simple ‘drug holiday’ strategy is highly dependent on the underlying mechanism of cell plasticity. For example, if the new cell state is maintained via hysteresis, drug holidays will not be able to reverse the phenotype for a long period of time<sup><a href="#ref-43">43</a></sup>.</p><p class="" id=d3732e835>In neuroendocrine transdifferentiation of prostate cancer, inhibition of EZH2 can actively reverse the lineage switch, thus restoring the sensitivity to enzalutamide treatment<sup><a href="#ref-23">23</a></sup>. Given the importance of EMT in cancer cell plasticity, actively reverting EMT by blocking TGFβ with forskolin and cholera toxin has been shown to promote MET and to sensitise these cells to anti-cancer therapies<sup><a href="#ref-79">79</a></sup>. In contrast, Ishay-Ronen <i>et al.</i> took advantage of EMT plasticity and treated mesenchymal-like breast cancer cells with rosiglitazone (PPAR inhibitor) and bone morphogenic protein 2 (BMP2) to further differentiate the tumour cells into adipocytes, thus impairing the drug tolerance<sup><a href="#ref-80">80</a></sup>. Although different strategies could be applied to control cell plasticity, insufficient evidence of clinical activity and difficulties in the determination of maximal tolerated doses and treatment schedules are still major challenges in therapeutics.</p></div><div class=section><a name=d3732e855 class=n-a></a><h3 class=section-title>3.4. Simple ordinary differential equation models of epithelial-to-mesenchymal transition including transient, hybrid cell subpopulations</h3><p class="" id=d3732e860>EMT is a paradigm of reversible cell plasticity and has been the object of many studies, not only from the experimental biology viewpoint (as mentioned earlier) but also from a systems biology viewpoint. An ODE setting has been proposed in which the model relies on gene regulatory networks involving <i>SNAIL</i>, <i>ZEB1</i>, miR-200 and miR-34 with multidirectional negative feedbacks. These networks can be controlled by external inputs on <i>SNAIL</i> expression, such as by TGFβ, nuclear factor kappa B (NFκB) and HIF1α. In a series of articles<sup><a href="#ref-81">81</a>–<a href="#ref-86">86</a></sup>, this fundamental circuit was elicited and modelled as a tristable ODE system and numerically explored, showing that between the two epithelial and mesenchymal stable states, an intermediate hybrid semistable state exists. It may be represented by a stable asymptotic branch in a bifurcation diagram, in which the bifurcation parameter may be chosen as the control input. Furthermore, in a 3D diagram (Figure 2 of ref. <a href="#ref-86">86</a>), an EMT axis has been proposed to be completed with an orthogonal differentiation axis<sup><a href="#ref-86">86</a></sup>, coding together for cell population heterogeneity in a cancer phenotype landscape whose definition remains to be made precise. Along this same line, also showing a tristable ODE system and using the same observed biological variables, another group of researchers obtained very comparable results<sup><a href="#ref-87">87</a></sup>.</p></div><div class=section><a name=d3732e892 class=n-a></a><h3 class=section-title>3.5. Combined drug delivery strategies relying on heterogeneous cell population mathematical models</h3><p class="" id=d3732e897>The first mathematical models proposed to represent drug resistance in heterogeneous cancer cell populations were compartmental ODE systems in which two distinct homogeneous subpopulations, either sensitive or resistant to anti-cancer drugs, were described by variables evolving with time under the influence of a time-scheduled drug delivery. Since then it has become possible to design optimised drug delivery strategies by using optimal control<sup><a href="#ref-88">88</a></sup>. In the 2017 study (by Carrère<sup><a href="#ref-88">88</a></sup>), the model parameters were identified from biological experiments by co-culturing epothilone-sensitive and -resistant cells of the same lineage (<a href="#f2">Figure 2A</a>). The optimisation problem to be solved is then to deliver the drug according to a periodic time schedule that minimises the total cancer cell population within a given finite therapeutic time window. However, one can argue that such a simplified co-culture system study ignores the reversibility of the non-genetic resistance that may be observed in clinically relevant situations<sup><a href="#ref-7">7</a>,<a href="#ref-89">89</a>,<a href="#ref-90">90</a></sup>, which raises major challenges for mathematical modelling: (1) drug resistance in these observations is reversible, and (2) it is induced by epigenetic enzymes, and any enzymatic activity, even with switching behaviour, is continuous. These two features cannot be obtained by ODE models. On the contrary, continuous phenotype-structured PDE models (<a href="#f2">Figures 2C–F</a>) capable of including any phenotype (that is, space, cell size, expression of drug resistance mechanisms, and so on), describing any relevant biological heterogeneity at stake in the cell population, can be applied<sup><a href="#ref-91">91</a>–<a href="#ref-98">98</a></sup>. Furthermore, drug delivery optimisation algorithms relying on optimal control can be designed on the basis of such models, leading to clinically transposable qualitative therapeutic strategies<sup><a href="#ref-93">93</a>,<a href="#ref-94">94</a></sup>. Other models that are often used in simulations of heterogeneous plastic cell populations are ABMs (also called individual-based models<sup><a href="#ref-19">19</a></sup>; <a href="#f2">Figure 2B</a>). Contrary to PDE models, that are deterministic, taking biological uncertainty into account by second-order terms (a Laplacian) or weighted population integrals, being nevertheless totally deterministic even in their numeric simulations, ABMs explicitly introduce stochasticity in simulations of biological processes by probabilistic laws. Note that it is possible, as mentioned earlier, to integrate by averaging and passing to the limit (in particular towards infinity in number and towards 0 in size of cells)<sup><a href="#ref-98">98</a></sup> ABMs into PDEs, easier to analyse and control. Here, we focused on proposed models of plastic cancer cell populations (sampled on <a href="#f2">Figure 2</a>) exposed (or to be exposed) to drugs and on drug delivery strategies and not on all possible models of plasticity in cancer cell populations. However, nothing in principle opposes the utilisation of therapeutic control strategies to the dynamics of stochastic models (ABMs) of different forms of cell plasticity or on molecular and cellular networks<sup><a href="#ref-99">99</a></sup> representing plasticity by molecular variations in very large systems of ODEs, stochastic differential equations or Boolean relations<sup><a href="#ref-100">100</a>–<a href="#ref-102">102</a></sup> in the framework of endogenous network theory (ENT)<sup><a href="#ref-103">103</a></sup> and the adaptive genetic landscape<sup><a href="#ref-104">104</a></sup>. Stochastic models could be called here, as they represent a relevant framework to capture the whole picture of plasticity in cancer. In particular, stochastic and ENT models<sup><a href="#ref-101">101</a>,<a href="#ref-103">103</a></sup>, as ODE models mentioned above about tristability in EMT models (that is, existence of an intermediate and transient state with intermediate characteristics between E and M states), are amenable to show an important feature of plasticity, namely the <i>possible</i> existence of transition states of phenotypes (an open question about the nature of plasticity mentioned in Section 2.1). Such transient states, as evidenced by EMT models, are of a qualitative nature and exist in a continuous range of parameters or system-determining variables, such as TGFβ or NFκB, which hopefully enable therapeutic control. In addition, so-called hybrid models (that is, both stochastic and continuous in their formulation), in which ABMs are used to represent the phenotypic behaviour of cell populations, with<sup><a href="#ref-105">105</a></sup> or without<sup><a href="#ref-98">98</a></sup> spatial cell growth, along with PDEs for the possible spatial diffusion of molecular species<sup><a href="#ref-105">105</a></sup>, have been proposed. Nevertheless, large systems of equations, such as the ones proposed in ENT models<sup><a href="#ref-101">101</a>,<a href="#ref-103">103</a></sup>, are not easy to handle. Indeed, one should bear in mind that the larger the system of equations, the harder it is to analyse and theoretically control, hence the mostly deterministic and not large network-like (thus here avowed as limited) point of view adopted in this mini-review, given that we aim at proposing simple models amenable to mathematical methods of optimal control to be used in the future in therapeutics.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d3732e1007>4. Emergent and non-standard viewpoints on cancer biology and possible therapeutic implications</h2><div class=section><a name=d3732e1010 class=n-a></a><h3 class=section-title>4.1. Tissue organisational field theory</h3><p class="" id=d3732e1015>Two main theories, representing reductionism and organicism, aim at understanding carcinogenesis. The reductionist single mutation theory (SMT) (the dominant theory) proposes that cancer is due to the genetic mutations of a single ‘renegade’ cell that begets all subsequent cancer cells. In contrast, the organicist tissue organisational field theory (TOFT)<sup><a href="#ref-106">106</a>,<a href="#ref-107">107</a></sup> proposes that disorganised tissues favour the emergence of neoplastic transformations. SMT and TOFT differ fundamentally from each other on the basis of aspects of the default cell state (quiescent or proliferative), reversibility (irreversible or reversible) and therapeutic strategy (killing cancer cells or exploiting tissue reversibility). Although cell plasticity is by no means central in SMT or in TOFT, it may be attached to both by a general ‘principle of variation’<sup><a href="#ref-108">108</a></sup>.</p></div><div class=section><a name=d3732e1030 class=n-a></a><h3 class=section-title>4.2. The Waddington epigenetic landscape revisited</h3><p class="" id=d3732e1035>Although the epigenetic landscape of Waddington was initially conceived as metaphoric ‘stemness potential’ valleys, Huang proposed the bifurcations between valleys of differentiation corresponding to stable asymptotic branches in bistable systems of ODEs<sup><a href="#ref-109">109</a></sup>. Huang <i>et al.</i><sup><a href="#ref-110">110</a></sup> (2007) proposed a detailed example of the <i>PU.1/GATA1</i> system of transcription factors which determines hematopoietic cell fates between the erythroid and myelomonocytic lineages. As mentioned in Section 1.3, this viewpoint allows us to illustrate plasticity in a population of cells endowed with the same genome by the instability of trajectories, in which appear ponds of non-differentiation, named ‘cancer attractors’ in which cells proliferate in a poorly differentiated state (this is illustrated on Figures 6 and 7 of Ref. <a href="#ref-109">109</a>). In this perspective, plasticity may be seen as a disorganisation of the epigenetic landscape, in which both differentiation and proliferation are uncontrolled. Note that ‘epigenetic’ here clearly means related to non-genetic modifications of the genome, due to differentiation, but in a sense that is completely independent of the molecular level of modifications of the chromatin (the ‘independence of senses’ refers to the opposition between the metaphoric representation of differentiations in the Waddington epigenetic landscape and the molecular determination of differentiations at the chromatin level). This point of view on plasticity in cancer is described by Pisco <i>et al.</i><sup><a href="#ref-89">89</a>,<a href="#ref-90">90</a></sup> and Huang <i>et al.</i><sup><a href="#ref-109">109</a>,<a href="#ref-110">110</a></sup>.</p></div><div class=section><a name=d3732e1074 class=n-a></a><h3 class=section-title>4.3. The atavistic theory of cancer</h3><p class="" id=d3732e1079>In 2011, physicists Paul Davies and Charles Lineweaver and oncologist Mark Vincent independently advocated the idea that ‘cancer is a de-repression of a default survival program common to all cells’<sup><a href="#ref-111">111</a></sup>, which was expressed by Davies and Lineweaver as the ‘atavistic theory of cancer’<sup><a href="#ref-112">112</a>,<a href="#ref-113">113</a></sup>. According to this theory, cancer is a disease of the evolution of multicellular organisms in which a localised collection of cells organises itself and proliferates for its own benefit. This hypothesis has been assessed from phylostratigraphic analyses of the genomes of different species that allowed investigators to establish links between the genes that are essential to multicellularity and those that are altered in cancer<sup><a href="#ref-114">114</a>,<a href="#ref-115">115</a></sup> and from more recent studies that elicit disrupted relationships between genes of multicellularity and genes that are disrupted in cancer<sup><a href="#ref-116">116</a>–<a href="#ref-119">119</a></sup>. Of course, this emerging field of research presupposes that cancer is an evolutionary disease of multicellular organisms; ‘evolutionary’ here means related to the Darwinian evolution of living species. In this respect, plasticity is clearly related to loss of control of the differentiations that make a multicellular organism coherent and functional, and any disruption in this control may lead to cancer without necessarily resorting to so-called CSCs. Along the same lines, it has been proposed that cancer cells are potentially resistant to letal drug insults by using bet-hedging strategies to diversify epigenetic programs. This point of view is developed in three review articles<sup><a href="#ref-120">120</a>–<a href="#ref-122">122</a></sup>. It is completely compatible with the representation of Waddington epigenetic landscape within which plasticity may be seen as a ‘flattening’ of the landscape by insufficient immune control on differentiations. More generally, independently of this metaphoric representation, we advocate that loss of control on differentiations, which is most likely related to defective control by the immune system (a view compatible with the ENT<sup><a href="#ref-104">104</a></sup> framework), <i>is</i> actually the plasticity of cancer.</p></div><div class=section><a name=d3732e1123 class=n-a></a><h3 class=section-title>4.4. Philosophy of cancer: cancer and the definition of an organism</h3><p class="" id=d3732e1128>The non-standard points of view mentioned above all lead to fundamental questions: What is an organism? What does cancer have to do with the underlying conception of an organism? These questions call for the intervention of philosophy of biology and in this case for the emergent philosophy of cancer.</p><p class="" id=d3732e1131>To make things clear, cancer being a disease of multicellular organisms (a cancerous bacterium simply does not make sense), the question of ‘what exactly is an organism?’ indeed arises quite naturally and this has been the case since Aristotle<sup><a href="#ref-123">123</a></sup>. It has been proposed that this notion may be defined in terms of the opposition between self and non-self, naturally introducing the immune system in this process. However, Thomas Pradeu<sup><a href="#ref-124">124</a>,<a href="#ref-125">125</a></sup>, presenting this question in most of its biological aspects, refutes this opposition as a working definition of an organism, proposing that the outskirts of a territory where there is immune response, that is, harsh immune interactions, are the limits of an organism. Whereas immune tolerance in the continuity of mild interactions between its components, on the contrary, defines what constitutes the inland territory of an organism. This quasi-phenomenological view of a multicellular organism, which ignores the genetic/epigenetic design (metaphorically illustrated by the Waddington epigenetic landscape relative to a single genome), has the merit of proposing an essential role for the immune system in answer to the question ‘What exactly is an organism?’ It also clearly presents cancer as a ‘deunification of an individual’<sup><a href="#ref-125">125</a></sup>. Nevertheless, we contend that this role of the immune system should not be thought of as only a functional one that is limited to the defence against pathogens. We propose that the epigenetic processes that control differentiations and are impaired in cancer – precisely whose alteration is cancer plasticity – are defined according to an ‘immune code’, which might be related to the major histocompatibility complex of vertebrates or to its forerunners in evolution. We thus suggest that the major role of the immune system, at least as important as to fight against pathogens, is to keep the integrity of the organism – hence defining it – by controlling differentiations. This establishes a link (common to all cancers) between the plasticity of cancer cell populations and an impairment of the immune system. It is consistent with views expressed by Guler <i>et al.</i> (2017)<sup><a href="#ref-36">36</a></sup>, who showed that DTPs escaped the IFN pathway, normally induced by repeat sequences, and with other views, expressed much earlier<sup><a href="#ref-126">126</a>,<a href="#ref-127">127</a></sup>, about ‘Urmetazoa’ that need a working immune system for their stability.</p><p class="" id=d3732e1164>The importance of CSCs<sup><a href="#ref-128">128</a></sup> has been put forth as the main determinant of cancer. It is currently the leading view in cancer biology, according to SMT (see Section 4.1), that cancer may be explained by a single renegade cell, the behaviour of which must be understood to unravel the complexity of cancer mechanisms. Unfortunately, the study of CSCs is often pursued per se and widely neglects that cancer is a disease of multicellular organisms with heterogeneous plasticity in cancer cell populations (that is, disrupted control of their differentiations).</p><p class="" id=d3732e1171>A general view of ancient and recent conceptions of cancer – nevertheless without the immunological vision that we and Thomas Pradeu advocate – may be found in Marta Bertolaso’s book<sup><a href="#ref-129">129</a></sup>. She does not choose between SMT and TOFT; rather, she proposes that the two theories are not necessarily incompatible with each other, a view that is also present in the ENT<sup><a href="#ref-104">104</a></sup> framework. In fact, we also propose that the essential resides elsewhere, possibly through the involvement of the immune system, and that an understanding of heterogeneity and plasticity in cancer should involve genetics/epigenetics, mathematical modelling, evolutionary biology and immunology. This is still a long transdisciplinary way to go.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d3732e1187>5. Concluding remarks</h2><p class="" id=d3732e1190>In this mini-review, we have tried to report striking observations and recent possible explanations of such facts, including less recent observations, that led us to explore the fields of cancer cell biology and medicine, systems biology, mathematical modelling and analysis, evolutionary biology, immunology, and philosophy of biology.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d3732e1197 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading is-hidden"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d4678>References</h2><div class="section ref-list"><a name=d3732e1197 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d3732e1204 class=n-a></a>Gómez Tejeda Zañudo J, Guinn MT, Farquhar K, <i> et al.</i>: Towards control of cellular decision-making networks in the epithelial-to-mesenchymal transition. <i>Phys Biol.</i> 2019; <b>16</b>(3): 31002. <a target=xrefwindow id=d3732e1215 href="http://www.ncbi.nlm.nih.gov/pubmed/30654341">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1218 href="https://doi.org/10.1088/1478-3975/aaffa1">Publisher Full Text </a> | <a target=xrefwindow id=d3732e1222 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6405305">Free Full Text </a></span><div class=note><a name=d3732e1224 class=n-a></a><p class=first id=d3732e1225><a target=xrefwindow href="https://facultyopinions.com/prime/734883241" id=d3732e1226>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d3732e1235 class=n-a></a>Aiello NM, Maddipati R, Norgard RJ, <i> et al.</i>: EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration. <i>Dev Cell.</i> 2018; <b>45</b>(6): 681–695.e4. <a target=xrefwindow id=d3732e1246 href="http://www.ncbi.nlm.nih.gov/pubmed/29920274">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1249 href="https://doi.org/10.1016/j.devcel.2018.05.027">Publisher Full Text </a> | <a target=xrefwindow id=d3732e1253 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6014628">Free Full Text </a></span><div class=note><a name=d3732e1255 class=n-a></a><p class=first id=d3732e1256><a target=xrefwindow href="https://facultyopinions.com/prime/733469566" id=d3732e1257>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d3732e1266 class=n-a></a>Weng CH, Chen LY, Lin YC, <i> et al.</i>: Epithelial-mesenchymal transition (EMT) beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI. <i>Oncogene.</i> 2019; <b>38</b>(4): 455–68. <a target=xrefwindow id=d3732e1277 href="http://www.ncbi.nlm.nih.gov/pubmed/30111817">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1280 href="https://doi.org/10.1038/s41388-018-0454-2">Publisher Full Text </a></span><div class=note><a name=d3732e1282 class=n-a></a><p class=first id=d3732e1283><a target=xrefwindow href="https://facultyopinions.com/prime/733826191" id=d3732e1284>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d3732e1293 class=n-a></a>Li S, Song Y, Quach C, <i> et al.</i>: Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance. <i>Nat Commun.</i> 2019; <b>10</b>(1): 1693. <a target=xrefwindow id=d3732e1304 href="http://www.ncbi.nlm.nih.gov/pubmed/30979895">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1307 href="https://doi.org/10.1038/s41467-019-09634-8">Publisher Full Text </a> | <a target=xrefwindow id=d3732e1311 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6461621">Free Full Text </a></span><div class=note><a name=d3732e1313 class=n-a></a><p class=first id=d3732e1314><a target=xrefwindow href="https://facultyopinions.com/prime/735543593" id=d3732e1315>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d3732e1324 class=n-a></a>Katsuno Y, Meyer DS, Zhang Z, <i> et al.</i>: Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition. <i>Sci Signal.</i> 2019; <b>12</b>(570): eaau8544. <a target=xrefwindow id=d3732e1335 href="http://www.ncbi.nlm.nih.gov/pubmed/30808819">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1338 href="https://doi.org/10.1126/scisignal.aau8544">Publisher Full Text </a> | <a target=xrefwindow id=d3732e1342 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6746178">Free Full Text </a></span><div class=note><a name=d3732e1344 class=n-a></a><p class=first id=d3732e1345><a target=xrefwindow href="https://facultyopinions.com/prime/735161036" id=d3732e1346>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d3732e1356 class=n-a></a>Fisher RA, Gollan B, Helaine S: Persistent bacterial infections and persister cells. <i>Nat Rev Microbiol.</i> 2017; <b>15</b>(8): 453–64. <a target=xrefwindow id=d3732e1364 href="http://www.ncbi.nlm.nih.gov/pubmed/28529326">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1367 href="https://doi.org/10.1038/nrmicro.2017.42">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d3732e1376 class=n-a></a>Sharma SV, Lee DY, Li B, <i> et al.</i>: A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. <i>Cell.</i> 2010; <b>141</b>(1): 69–80. <a target=xrefwindow id=d3732e1387 href="http://www.ncbi.nlm.nih.gov/pubmed/20371346">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1390 href="https://doi.org/10.1016/j.cell.2010.02.027">Publisher Full Text </a> | <a target=xrefwindow id=d3732e1394 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2851638">Free Full Text </a></span><div class=note><a name=d3732e1396 class=n-a></a><p class=first id=d3732e1397><a target=xrefwindow href="https://facultyopinions.com/prime/2832960" id=d3732e1398>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d3732e1407 class=n-a></a>Liau BB, Sievers C, Donohue LK, <i> et al.</i>: Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance. <i>Cell Stem Cell.</i> 2017; <b>20</b>(2): 233–246.e7. <a target=xrefwindow id=d3732e1418 href="http://www.ncbi.nlm.nih.gov/pubmed/27989769">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1421 href="https://doi.org/10.1016/j.stem.2016.11.003">Publisher Full Text </a> | <a target=xrefwindow id=d3732e1425 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5291795">Free Full Text </a></span><div class=note><a name=d3732e1427 class=n-a></a><p class=first id=d3732e1428><a target=xrefwindow href="https://facultyopinions.com/prime/727120897" id=d3732e1429>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d3732e1438 class=n-a></a>Shen S, Faouzi S, Bastide A, <i> et al.</i>: An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cells. <i>Nat Commun.</i> 2019; <b>10</b>(1): 5713. <a target=xrefwindow id=d3732e1449 href="http://www.ncbi.nlm.nih.gov/pubmed/31844050">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1452 href="https://doi.org/10.1038/s41467-019-13360-6">Publisher Full Text </a> | <a target=xrefwindow id=d3732e1456 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6915789">Free Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d3732e1465 class=n-a></a>Rabé M, Dumont S, Álvarez-Arenas A, <i> et al.</i>: Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma. <i>Cell Death Dis.</i> 2020; <b>11</b>: 19. <a target=xrefwindow id=d3732e1476 href="http://www.ncbi.nlm.nih.gov/pubmed/31907355">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1479 href="https://doi.org/10.1038/s41419-019-2200-2">Publisher Full Text </a> | <a target=xrefwindow id=d3732e1483 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6944699">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d3732e1492 class=n-a></a>Biehs B, Dijkgraaf GJP, Piskol R, <i> et al.</i>: A cell identity switch allows residual BCC to survive Hedgehog pathway inhibition. <i>Nature.</i> 2018; <b>562</b>(7727): 429–33. <a target=xrefwindow id=d3732e1503 href="http://www.ncbi.nlm.nih.gov/pubmed/30297801">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1506 href="https://doi.org/10.1038/s41586-018-0596-y">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d3732e1516 class=n-a></a>Sánchez-Danés A, Larsimont JC, Liagre M, <i> et al.</i>: A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy. <i>Nature.</i> 2018; <b>562</b>(7727): 434–8. <a target=xrefwindow id=d3732e1527 href="http://www.ncbi.nlm.nih.gov/pubmed/30297799">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1530 href="https://doi.org/10.1038/s41586-018-0603-3">Publisher Full Text </a> | <a target=xrefwindow id=d3732e1534 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6295195">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d3732e1543 class=n-a></a>Rambow F, Rogiers A, Marin-Bejar O, <i> et al.</i>: Toward Minimal Residual Disease-Directed Therapy in Melanoma. <i>Cell.</i> 2018; <b>174</b>(4): 843–855.e19. <a target=xrefwindow id=d3732e1554 href="http://www.ncbi.nlm.nih.gov/pubmed/30017245">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1557 href="https://doi.org/10.1016/j.cell.2018.06.025">Publisher Full Text </a></span><div class=note><a name=d3732e1559 class=n-a></a><p class=first id=d3732e1560><a target=xrefwindow href="https://facultyopinions.com/prime/733626181" id=d3732e1561>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d3732e1570 class=n-a></a>Aloia A, Müllhaupt D, Chabbert CD, <i> et al.</i>: A Fatty Acid Oxidation-dependent Metabolic Shift Regulates the Adaptation of <i>BRAF</i>-mutated Melanoma to MAPK Inhibitors. <i>Clin Cancer Res.</i> 2019; <b>25</b>(22): 6852–67. <a target=xrefwindow id=d3732e1584 href="http://www.ncbi.nlm.nih.gov/pubmed/31375515">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1588 href="https://doi.org/10.1158/1078-0432.CCR-19-0253">Publisher Full Text </a> | <a target=xrefwindow id=d3732e1591 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6906212">Free Full Text </a></span><div class=note><a name=d3732e1593 class=n-a></a><p class=first id=d3732e1594><a target=xrefwindow href="https://facultyopinions.com/prime/736337711" id=d3732e1595>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d3732e1604 class=n-a></a>Vivas-García Y, Falletta P, Liebing J, <i> et al.</i>: Lineage-Restricted Regulation of SCD and Fatty Acid Saturation by MITF Controls Melanoma Phenotypic Plasticity. <i>Mol Cell.</i> 2020; <b>77</b>(1): 120–137.e9. <a target=xrefwindow id=d3732e1615 href="http://www.ncbi.nlm.nih.gov/pubmed/31733993">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1618 href="https://doi.org/10.1016/j.molcel.2019.10.014">Publisher Full Text </a> | <a target=xrefwindow id=d3732e1622 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7137507">Free Full Text </a></span><div class=note><a name=d3732e1624 class=n-a></a><p class=first id=d3732e1625><a target=xrefwindow href="https://facultyopinions.com/prime/736926664" id=d3732e1626>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d3732e1635 class=n-a></a>Shaffer SM, Dunagin MC, Torborg SR, <i> et al.</i>: Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. <i>Nature.</i> 2017; <b>546</b>(7658): 431–5. <a target=xrefwindow id=d3732e1646 href="http://www.ncbi.nlm.nih.gov/pubmed/28607484">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1649 href="https://doi.org/10.1038/nature22794">Publisher Full Text </a> | <a target=xrefwindow id=d3732e1653 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5542814">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d3732e1662 class=n-a></a>Blake WJ, Balázsi G, Kohanski MA, <i> et al.</i>: Phenotypic consequences of promoter-mediated transcriptional noise. <i>Mol Cell.</i> 2006; <b>24</b>(6): 853–65. <a target=xrefwindow id=d3732e1673 href="http://www.ncbi.nlm.nih.gov/pubmed/17189188">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1676 href="https://doi.org/10.1016/j.molcel.2006.11.003">Publisher Full Text </a></span><div class=note><a name=d3732e1678 class=n-a></a><p class=first id=d3732e1679><a target=xrefwindow href="https://facultyopinions.com/prime/1066860" id=d3732e1680>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d3732e1690 class=n-a></a>Farquhar KS, Charlebois DA, Szenk M, <i> et al.</i>: Role of network-mediated stochasticity in mammalian drug resistance. <i>Nat Commun.</i> 2019; <b>10</b>(1): 2766. <a target=xrefwindow id=d3732e1701 href="http://www.ncbi.nlm.nih.gov/pubmed/31235692">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1704 href="https://doi.org/10.1038/s41467-019-10330-w">Publisher Full Text </a> | <a target=xrefwindow id=d3732e1708 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6591227">Free Full Text </a></span><div class=note><a name=d3732e1710 class=n-a></a><p class=first id=d3732e1711><a target=xrefwindow href="https://facultyopinions.com/prime/736040460" id=d3732e1712>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d3732e1721 class=n-a></a>Chisholm RH, Lorenzi T, Lorz A, <i> et al.</i>: Emergence of drug tolerance in cancer cell populations: An evolutionary outcome of selection, nongenetic instability, and stress-induced adaptation. <i>Cancer Res.</i> 2015; <b>75</b>(6): 930–9. <a target=xrefwindow id=d3732e1732 href="http://www.ncbi.nlm.nih.gov/pubmed/25627977">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1735 href="https://doi.org/10.1158/0008-5472.CAN-14-2103">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d3732e1744 class=n-a></a>Bakshi A, Chaudhary SC, Rana M, <i> et al.</i>: Basal cell carcinoma pathogenesis and therapy involving hedgehog signaling and beyond. <i>Mol Carcinog.</i> 2017; <b>56</b>(12): 2543–57. <a target=xrefwindow id=d3732e1755 href="http://www.ncbi.nlm.nih.gov/pubmed/28574612">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1758 href="https://doi.org/10.1002/mc.22690">Publisher Full Text </a> | <a target=xrefwindow id=d3732e1762 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5962346">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d3732e1771 class=n-a></a>Zou M, Toivanen R, Mitrofanova A, <i> et al.</i>: Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer. <i>Cancer Discov.</i> 2017; <b>7</b>(7): 736–49. <a target=xrefwindow id=d3732e1782 href="http://www.ncbi.nlm.nih.gov/pubmed/28411207">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1785 href="https://doi.org/10.1158/2159-8290.CD-16-1174">Publisher Full Text </a> | <a target=xrefwindow id=d3732e1789 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5501744">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d3732e1798 class=n-a></a>Mu P, Zhang Z, Benelli M, <i> et al.</i>: <i>SOX2</i> promotes lineage plasticity and antiandrogen resistance in <i>TP53</i>- and <i>RB1</i>-deficient prostate cancer. <i>Science.</i> 2017; <b>355</b>(6320): 84–8. <a target=xrefwindow id=d3732e1819 href="http://www.ncbi.nlm.nih.gov/pubmed/28059768">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1822 href="https://doi.org/10.1126/science.aah4307">Publisher Full Text </a> | <a target=xrefwindow id=d3732e1825 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5247742">Free Full Text </a></span><div class=note><a name=d3732e1827 class=n-a></a><p class=first id=d3732e1828><a target=xrefwindow href="https://facultyopinions.com/prime/727173550" id=d3732e1829>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d3732e1838 class=n-a></a>Ku SY, Rosario S, Wang Y, <i> et al.</i>: <i>Rb1</i> and <i>Trp53</i> cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance. <i>Science.</i> 2017; <b>355</b>(6320): 78–83. <a target=xrefwindow id=d3732e1856 href="http://www.ncbi.nlm.nih.gov/pubmed/28059767">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1859 href="https://doi.org/10.1126/science.aah4199">Publisher Full Text </a> | <a target=xrefwindow id=d3732e1862 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5367887">Free Full Text </a></span><div class=note><a name=d3732e1864 class=n-a></a><p class=first id=d3732e1865><a target=xrefwindow href="https://facultyopinions.com/prime/727164983" id=d3732e1866>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d3732e1876 class=n-a></a>Lee JK, Lee J, Kim S, <i> et al.</i>: Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas. <i>J Clin Oncol.</i> 2017; <b>35</b>(26): 3065–74. <a target=xrefwindow id=d3732e1887 href="http://www.ncbi.nlm.nih.gov/pubmed/28498782">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1890 href="https://doi.org/10.1200/JCO.2016.71.9096">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d3732e1899 class=n-a></a>Marcoux N, Gettinger SN, O'Kane G, <i> et al.</i>: <i>EGFR</i>-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes. <i>J Clin Oncol.</i> 2019; <b>37</b>(4): 278–85. <a target=xrefwindow id=d3732e1913 href="http://www.ncbi.nlm.nih.gov/pubmed/30550363">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1917 href="https://doi.org/10.1200/JCO.18.01585">Publisher Full Text </a> | <a target=xrefwindow id=d3732e1920 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7001776">Free Full Text </a></span><div class=note><a name=d3732e1922 class=n-a></a><p class=first id=d3732e1923><a target=xrefwindow href="https://facultyopinions.com/prime/734631993" id=d3732e1924>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d3732e1933 class=n-a></a>Kohutek ZA, Rosati LM, Hong J, <i> et al.</i>: An unusual genomic variant of pancreatic ductal adenocarcinoma with an indolent clinical course. <i>Cold Spring Harb Mol Case Stud.</i> 2017; <b>3</b>(4): a001701. <a target=xrefwindow id=d3732e1944 href="http://www.ncbi.nlm.nih.gov/pubmed/28679692">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1947 href="https://doi.org/10.1101/mcs.a001701">Publisher Full Text </a> | <a target=xrefwindow id=d3732e1951 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5495033">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d3732e1960 class=n-a></a>Agarwal A, Bolosky WJ, Wilson DB, <i> et al.</i>: Differentiation of leukemic blasts is not completely blocked in acute myeloid leukemia. <i>Proc Natl Acad Sci U S A.</i> 2019; <b>116</b>(49): 24593–9. <a target=xrefwindow id=d3732e1971 href="http://www.ncbi.nlm.nih.gov/pubmed/31754026">PubMed Abstract </a> | <a target=xrefwindow id=d3732e1974 href="https://doi.org/10.1073/pnas.1904091116">Publisher Full Text </a> | <a target=xrefwindow id=d3732e1978 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6900505">Free Full Text </a></span><div class=note><a name=d3732e1980 class=n-a></a><p class=first id=d3732e1981><a target=xrefwindow href="https://facultyopinions.com/prime/736969647" id=d3732e1982>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d3732e1991 class=n-a></a>Huang ME, Ye YC, Chen SR, <i> et al.</i>: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. <i>Blood.</i> 1988; <b>72</b>(2): 567–72. <a target=xrefwindow id=d3732e2002 href="http://www.ncbi.nlm.nih.gov/pubmed/3165295">PubMed Abstract </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d3732e2011 class=n-a></a>Zajac O, Raingeaud J, Libanje F, <i> et al.</i>: Tumour spheres with inverted polarity drive the formation of peritoneal metastases in patients with hypermethylated colorectal carcinomas. <i>Nat Cell Biol.</i> 2018; <b>20</b>(3): 296–306. <a target=xrefwindow id=d3732e2022 href="http://www.ncbi.nlm.nih.gov/pubmed/29403038">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2025 href="https://doi.org/10.1038/s41556-017-0027-6">Publisher Full Text </a></span><div class=note><a name=d3732e2027 class=n-a></a><p class=first id=d3732e2028><a target=xrefwindow href="https://facultyopinions.com/prime/732609524" id=d3732e2029>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d3732e2039 class=n-a></a>Tripathi S, Jolly MK, Woodward WA, <i> et al.</i>: Analysis of Hierarchical Organization in Gene Expression Networks Reveals Underlying Principles of Collective Tumor Cell Dissemination and Metastatic Aggressiveness of Inflammatory Breast Cancer. <i>Front Oncol.</i> 2018; <b>8</b>: 244. <a target=xrefwindow id=d3732e2050 href="http://www.ncbi.nlm.nih.gov/pubmed/30023340">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2053 href="https://doi.org/10.3389/fonc.2018.00244">Publisher Full Text </a> | <a target=xrefwindow id=d3732e2057 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6039554">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d3732e2066 class=n-a></a>Murlidhar V, Reddy RM, Fouladdel S, <i> et al.</i>: Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers. <i>Cancer Res.</i> 2017; <b>77</b>(18): 5194–206. <a target=xrefwindow id=d3732e2077 href="http://www.ncbi.nlm.nih.gov/pubmed/28716896">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2080 href="https://doi.org/10.1158/0008-5472.CAN-16-2072">Publisher Full Text </a> | <a target=xrefwindow id=d3732e2084 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5600850">Free Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d3732e2093 class=n-a></a>Richardson AM, Havel LS, Koyen AE, <i> et al.</i>: Vimentin Is Required for Lung Adenocarcinoma Metastasis via Heterotypic Tumor Cell-Cancer-Associated Fibroblast Interactions during Collective Invasion. <i>Clin Cancer Res.</i> 2018; <b>24</b>(2): 420–32. <a target=xrefwindow id=d3732e2104 href="http://www.ncbi.nlm.nih.gov/pubmed/29208669">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2107 href="https://doi.org/10.1158/1078-0432.CCR-17-1776">Publisher Full Text </a> | <a target=xrefwindow id=d3732e2111 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5771825">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d3732e2120 class=n-a></a>You JS, Jones PA: Cancer Genetics and Epigenetics: Two Sides of the Same Coin? <i>Cancer Cell.</i> 2012; <b>22</b>(1): 9–20. <a target=xrefwindow id=d3732e2128 href="http://www.ncbi.nlm.nih.gov/pubmed/22789535">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2131 href="https://doi.org/10.1016/j.ccr.2012.06.008">Publisher Full Text </a> | <a target=xrefwindow id=d3732e2134 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3396881">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d3732e2143 class=n-a></a>Vinogradova M, Gehling VS, Gustafson A, <i> et al.</i>: An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells. <i>Nat Chem Biol.</i> 2016; <b>12</b>(7): 531–8. <a target=xrefwindow id=d3732e2154 href="http://www.ncbi.nlm.nih.gov/pubmed/27214401">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2157 href="https://doi.org/10.1038/nchembio.2085">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d3732e2166 class=n-a></a>Roesch A, Vultur A, Bogeski I, <i> et al.</i>: Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B<sup>high</sup> cells. <i>Cancer Cell.</i> 2013; <b>23</b>(6): 811–25. <a target=xrefwindow id=d3732e2180 href="http://www.ncbi.nlm.nih.gov/pubmed/23764003">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2184 href="https://doi.org/10.1016/j.ccr.2013.05.003">Publisher Full Text </a> | <a target=xrefwindow id=d3732e2187 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3810180">Free Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d3732e2197 class=n-a></a>Guler GD, Tindell CA, Pitti R, <i> et al.</i>: Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure. <i>Cancer Cell.</i> 2017; <b>32</b>(2): 221–237.e13. <a target=xrefwindow id=d3732e2208 href="http://www.ncbi.nlm.nih.gov/pubmed/2878112">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2211 href="https://doi.org/10.1016/j.ccell.2017.07.002">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d3732e2220 class=n-a></a>Song C, Piva M, Sun L, <i> et al.</i>: Recurrent Tumor Cell-Intrinsic and -Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early Adaptation. <i>Cancer Discov.</i> 2017; <b>7</b>: 1248–65. <a target=xrefwindow id=d3732e2231 href="https://doi.org/10.1158/2159-8290.CD-17-0401">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d3732e2240 class=n-a></a>Al Emran A, Marzese DM, Menon DR, <i> et al.</i>: Distinct histone modifications denote early stress-induced drug tolerance in cancer. <i>Oncotarget.</i> 2017; <b>9</b>(9): 8206–22. <a target=xrefwindow id=d3732e2251 href="http://www.ncbi.nlm.nih.gov/pubmed/29492189">PubMed Abstract </a> | |<a target=xrefwindow id=d3732e2254 href="https://doi.org/10.18632/oncotarget.23654">Publisher Full Text </a> | <a target=xrefwindow id=d3732e2258 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5823586">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d3732e2267 class=n-a></a>Benci JL, Johnson LR, Choa R, <i> et al.</i>: Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade. <i>Cell.</i> 2019; <b>178</b>(4): 933–948.e14. <a target=xrefwindow id=d3732e2278 href="http://www.ncbi.nlm.nih.gov/pubmed/31398344">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2281 href="https://doi.org/10.1016/j.cell.2019.07.019">Publisher Full Text </a> | <a target=xrefwindow id=d3732e2285 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6830508">Free Full Text </a></span><div class=note><a name=d3732e2287 class=n-a></a><p class=first id=d3732e2288><a target=xrefwindow href="https://facultyopinions.com/prime/736362848" id=d3732e2289>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d3732e2298 class=n-a></a>Russo M, Crisafulli G, Sogari A, <i> et al.</i>: Adaptive mutability of colorectal cancers in response to targeted therapies. <i>Science.</i> 2019; <b>366</b>(6472): 1473–80. <a target=xrefwindow id=d3732e2309 href="http://www.ncbi.nlm.nih.gov/pubmed/31699882">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2312 href="https://doi.org/10.1126/science.aav4474">Publisher Full Text </a></span><div class=note><a name=d3732e2314 class=n-a></a><p class=first id=d3732e2315><a target=xrefwindow href="https://facultyopinions.com/prime/736869799" id=d3732e2316>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d3732e2325 class=n-a></a>Xie W, Kagiampakis I, Pan L, <i> et al.</i>: DNA Methylation Patterns Separate Senescence from Transformation Potential and Indicate Cancer Risk. <i>Cancer Cell.</i> 2018; <b>33</b>(2): 309–321.e5. <a target=xrefwindow id=d3732e2336 href="http://www.ncbi.nlm.nih.gov/pubmed/29438699">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2339 href="https://doi.org/10.1016/j.ccell.2018.01.008">Publisher Full Text </a> | <a target=xrefwindow id=d3732e2343 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5813821">Free Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d3732e2353 class=n-a></a>Huang S, Li F, Zhou JX, <i> et al.</i>: Processes on the emergent landscapes of biochemical reaction networks and heterogeneous cell population dynamics: Differentiation in living matters. <i>J R Soc Interface.</i> 2017; <b>14</b>(130): 20170097. <a target=xrefwindow id=d3732e2364 href="http://www.ncbi.nlm.nih.gov/pubmed/28490602">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2367 href="https://doi.org/10.1098/rsif.2017.0097">Publisher Full Text </a> | <a target=xrefwindow id=d3732e2371 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5454298">Free Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d3732e2380 class=n-a></a>Celià-Terrassa T, Bastian C, Liu DD, <i> et al.</i>: Hysteresis control of epithelial-mesenchymal transition dynamics conveys a distinct program with enhanced metastatic ability. <i>Nat Commun.</i> 2018; <b>9</b>(1): 5005. <a target=xrefwindow id=d3732e2391 href="http://www.ncbi.nlm.nih.gov/pubmed/30479345">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2394 href="https://doi.org/10.1038/s41467-018-07538-7">Publisher Full Text </a> | <a target=xrefwindow id=d3732e2398 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6258667">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d3732e2407 class=n-a></a>Kang Y, Massagué J: Epithelial-mesenchymal transitions: Twist in development and metastasis. <i>Cell.</i> 2004; <b>118</b>(3): 277–9. <a target=xrefwindow id=d3732e2415 href="http://www.ncbi.nlm.nih.gov/pubmed/15294153">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2418 href="https://doi.org/10.1016/j.cell.2004.07.011">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d3732e2427 class=n-a></a>He J, Lee HJ, Saha S, <i> et al.</i>: Inhibition of USP2 eliminates cancer stem cells and enhances TNBC responsiveness to chemotherapy. <i>Cell Death Dis.</i> 2019; <b>10</b>(4): 285. <a target=xrefwindow id=d3732e2438 href="http://www.ncbi.nlm.nih.gov/pubmed/30918246">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2441 href="https://doi.org/10.1038/s41419-019-1512-6">Publisher Full Text </a> | <a target=xrefwindow id=d3732e2445 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6437220">Free Full Text </a></span><div class=note><a name=d3732e2447 class=n-a></a><p class=first id=d3732e2448><a target=xrefwindow href="https://facultyopinions.com/prime/735413378" id=d3732e2449>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d3732e2458 class=n-a></a>Lee J, Lee J, Farquhar KS, <i> et al.</i>: Network of mutually repressive metastasis regulators can promote cell heterogeneity and metastatic transitions. <i>Proc Natl Acad Sci U S A.</i> 2014; <b>111</b>(3): E364–73. <a target=xrefwindow id=d3732e2469 href="http://www.ncbi.nlm.nih.gov/pubmed/24395801">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2472 href="https://doi.org/10.1073/pnas.1304840111">Publisher Full Text </a> | <a target=xrefwindow id=d3732e2476 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3903259">Free Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d3732e2485 class=n-a></a>Kurppa KJ, Liu Y, To C, <i> et al.</i>: Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway. <i>Cancer Cell.</i> 2020; <b>37</b>(1): 104–122.e12. <a target=xrefwindow id=d3732e2496 href="http://www.ncbi.nlm.nih.gov/pubmed/31935369">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2499 href="https://doi.org/10.1016/j.ccell.2019.12.006">Publisher Full Text </a> | <a target=xrefwindow id=d3732e2503 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7146079">Free Full Text </a></span><div class=note><a name=d3732e2505 class=n-a></a><p class=first id=d3732e2506><a target=xrefwindow href="https://facultyopinions.com/prime/737201348" id=d3732e2507>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d3732e2517 class=n-a></a>Moparthi L, Pizzolato G, Koch S: Wnt activator FOXB2 drives the neuroendocrine differentiation of prostate cancer. <i>Proc Natl Acad Sci U S A.</i> 2019; <b>116</b>(44): 22189–95. <a target=xrefwindow id=d3732e2525 href="http://www.ncbi.nlm.nih.gov/pubmed/31611391">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2528 href="https://doi.org/10.1073/pnas.1906484116">Publisher Full Text </a> | <a target=xrefwindow id=d3732e2531 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6825314">Free Full Text </a></span><div class=note><a name=d3732e2533 class=n-a></a><p class=first id=d3732e2534><a target=xrefwindow href="https://facultyopinions.com/prime/736758398" id=d3732e2535>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d3732e2544 class=n-a></a>Yan J, Chen SAA, Local A, <i> et al.</i>: Histone H3 lysine 4 monomethylation modulates long-range chromatin interactions at enhancers. <i>Cell Res.</i> 2018; <b>28</b>(2): 204–20. <a target=xrefwindow id=d3732e2555 href="http://www.ncbi.nlm.nih.gov/pubmed/29313530">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2558 href="https://doi.org/10.1038/cr.2018.1">Publisher Full Text </a> | <a target=xrefwindow id=d3732e2562 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5799818">Free Full Text </a></span><div class=note><a name=d3732e2564 class=n-a></a><p class=first id=d3732e2565><a target=xrefwindow href="https://facultyopinions.com/prime/732438469" id=d3732e2566>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d3732e2575 class=n-a></a>Baskar R, Fienberg HG, Khair Z, <i> et al.</i>: TRAIL-induced variation of cell signaling states provides nonheritable resistance to apoptosis. <i>Life Sci Alliance.</i> 2019; <b>2</b>(6): e201900554. <a target=xrefwindow id=d3732e2586 href="http://www.ncbi.nlm.nih.gov/pubmed/31704709">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2589 href="https://doi.org/10.26508/lsa.201900554">Publisher Full Text </a> | <a target=xrefwindow id=d3732e2593 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6848270">Free Full Text </a></span><div class=note><a name=d3732e2595 class=n-a></a><p class=first id=d3732e2596><a target=xrefwindow href="https://facultyopinions.com/prime/736873710" id=d3732e2597>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d3732e2606 class=n-a></a>Hirata E, Girotti MR, Viros A, <i> et al.</i>: Intravital imaging reveals how BRAF inhibition generates drug-tolerant microenvironments with high integrin β1/FAK signaling. <i>Cancer Cell.</i> 2015; <b>27</b>(4): 574–88. <a target=xrefwindow id=d3732e2617 href="http://www.ncbi.nlm.nih.gov/pubmed/25873177">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2620 href="https://doi.org/10.1016/j.ccell.2015.03.008">Publisher Full Text </a> | <a target=xrefwindow id=d3732e2624 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4402404">Free Full Text </a></span><div class=note><a name=d3732e2626 class=n-a></a><p class=first id=d3732e2627><a target=xrefwindow href="https://facultyopinions.com/prime/725435550" id=d3732e2628>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d3732e2637 class=n-a></a>Watson SS, Dane M, Chin K, <i> et al.</i>: Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes. <i>Cell Syst.</i> 2018; <b>6</b>(3): 329–342.e6. <a target=xrefwindow id=d3732e2648 href="http://www.ncbi.nlm.nih.gov/pubmed/29550255">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2651 href="https://doi.org/10.1016/j.cels.2018.02.001">Publisher Full Text </a> | <a target=xrefwindow id=d3732e2655 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5927625">Free Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d3732e2664 class=n-a></a>Apicella M, Giannoni E, Fiore S, <i> et al.</i>: Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies. <i>Cell Metab.</i> 2018; <b>28</b>(6): 848–865.e6. <a target=xrefwindow id=d3732e2675 href="http://www.ncbi.nlm.nih.gov/pubmed/30174307">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2678 href="https://doi.org/10.1016/j.cmet.2018.08.006">Publisher Full Text </a></span><div class=note><a name=d3732e2680 class=n-a></a><p class=first id=d3732e2681><a target=xrefwindow href="https://facultyopinions.com/prime/733887765" id=d3732e2682>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d3732e2692 class=n-a></a>Glodde N, Bald T, van den Boorn-Konijnenberg D, <i> et al.</i>: Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy. <i>Immunity.</i> 2017; <b>47</b>(4): 789–802.e9. <a target=xrefwindow id=d3732e2703 href="http://www.ncbi.nlm.nih.gov/pubmed/29045907">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2706 href="https://doi.org/10.1016/j.immuni.2017.09.012">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d3732e2715 class=n-a></a>Canli Ö, Nicolas AM, Gupta J, <i> et al.</i>: Myeloid Cell-Derived Reactive Oxygen Species Induce Epithelial Mutagenesis. <i>Cancer Cell.</i> 2017; <b>32</b>(6): 869–883.e5. <a target=xrefwindow id=d3732e2726 href="http://www.ncbi.nlm.nih.gov/pubmed/29232557">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2729 href="https://doi.org/10.1016/j.ccell.2017.11.004">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d3732e2738 class=n-a></a>Cassetta L, Pollard JW: Targeting macrophages: Therapeutic approaches in cancer. <i>Nat Rev Drug Discov.</i> 2018; <b>17</b>(12): 887–904. <a target=xrefwindow id=d3732e2746 href="http://www.ncbi.nlm.nih.gov/pubmed/30361552">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2749 href="https://doi.org/10.1038/nrd.2018.169">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d3732e2758 class=n-a></a>Mazzone M, Menga A, Castegna A: Metabolism and TAM functions-it takes two to tango. <i>FEBS J.</i> 2018; <b>285</b>(4): 700–16. <a target=xrefwindow id=d3732e2766 href="http://www.ncbi.nlm.nih.gov/pubmed/29055087">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2769 href="https://doi.org/10.1111/febs.14295">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d3732e2778 class=n-a></a>Allen E, Miéville P, Warren CM, <i> et al.</i>: Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling. <i>Cell Rep.</i> 2016; <b>15</b>(6): 1144–60. <a target=xrefwindow id=d3732e2789 href="http://www.ncbi.nlm.nih.gov/pubmed/27134166">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2792 href="https://doi.org/10.1016/j.celrep.2016.04.029">Publisher Full Text </a> | <a target=xrefwindow id=d3732e2796 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4872464">Free Full Text </a></span><div class=note><a name=d3732e2798 class=n-a></a><p class=first id=d3732e2799><a target=xrefwindow href="https://facultyopinions.com/prime/726325892" id=d3732e2800>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d3732e2809 class=n-a></a>Liu N, Luo J, Kuang D, <i> et al.</i>: Lactate inhibits ATP6V0d2 expression in tumor-associated macrophages to promote HIF-2α-mediated tumor progression. <i>J Clin Invest.</i> 2019; <b>129</b>(2): 631–46. <a target=xrefwindow id=d3732e2820 href="http://www.ncbi.nlm.nih.gov/pubmed/30431439">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2823 href="https://doi.org/10.1172/JCI123027">Publisher Full Text </a> | <a target=xrefwindow id=d3732e2827 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6355226">Free Full Text </a></span><div class=note><a name=d3732e2829 class=n-a></a><p class=first id=d3732e2830><a target=xrefwindow href="https://facultyopinions.com/prime/734441266" id=d3732e2831>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d3732e2841 class=n-a></a>Bohn T, Rapp S, Luther N, <i> et al.</i>: Tumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophages. <i>Nat Immunol.</i> 2018; <b>19</b>(12): 1319–29. <a target=xrefwindow id=d3732e2852 href="http://www.ncbi.nlm.nih.gov/pubmed/30397348">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2855 href="https://doi.org/10.1038/s41590-018-0226-8">Publisher Full Text </a></span><div class=note><a name=d3732e2857 class=n-a></a><p class=first id=d3732e2858><a target=xrefwindow href="https://facultyopinions.com/prime/734361712" id=d3732e2859>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d3732e2868 class=n-a></a>Zhang Y, Yu G, Chu H, <i> et al.</i>: Macrophage-Associated PGK1 Phosphorylation Promotes Aerobic Glycolysis and Tumorigenesis. <i>Mol Cell.</i> 2018; <b>71</b>(2): 201–215.e7. <a target=xrefwindow id=d3732e2879 href="http://www.ncbi.nlm.nih.gov/pubmed/30029001">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2882 href="https://doi.org/10.1016/j.molcel.2018.06.023">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d3732e2891 class=n-a></a>Chen F, Chen J, Yang L, <i> et al.</i>: Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells. <i>Nat Cell Biol.</i> 2019; <b>21</b>(4): 498–510. <a target=xrefwindow id=d3732e2902 href="http://www.ncbi.nlm.nih.gov/pubmed/30936474">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2905 href="https://doi.org/10.1038/s41556-019-0299-0">Publisher Full Text </a></span><div class=note><a name=d3732e2908 class=n-a></a><p class=first id=d3732e2909><a target=xrefwindow href="https://facultyopinions.com/prime/735435835" id=d3732e2910>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d3732e2919 class=n-a></a>Halbrook CJ, Pontious C, Kovalenko I, <i> et al.</i>: Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer. <i>Cell Metab.</i> 2019; <b>29</b>(6): 1390–1399.e6. <a target=xrefwindow id=d3732e2930 href="http://www.ncbi.nlm.nih.gov/pubmed/30827862">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2933 href="https://doi.org/10.1016/j.cmet.2019.02.001">Publisher Full Text </a> | <a target=xrefwindow id=d3732e2937 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6602533">Free Full Text </a></span><div class=note><a name=d3732e2940 class=n-a></a><p class=first id=d3732e2941><a target=xrefwindow href="https://facultyopinions.com/prime/735240304" id=d3732e2942>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d3732e2951 class=n-a></a>Venkatesh HS, Tam LT, Woo PJ, <i> et al.</i>: Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma. <i>Nature.</i> 2017; <b>549</b>(7673): 533–7. <a target=xrefwindow id=d3732e2962 href="http://www.ncbi.nlm.nih.gov/pubmed/28959975">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2965 href="https://doi.org/10.1038/nature24014">Publisher Full Text </a> | <a target=xrefwindow id=d3732e2969 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5891832">Free Full Text </a></span><div class=note><a name=d3732e2972 class=n-a></a><p class=first id=d3732e2973><a target=xrefwindow href="https://facultyopinions.com/prime/731247154" id=d3732e2974>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d3732e2983 class=n-a></a>Boilly B, Faulkner S, Jobling P, <i> et al.</i>: Nerve Dependence: From Regeneration to Cancer. <i>Cancer Cell.</i> 2017; <b>31</b>(3): 342–54. <a target=xrefwindow id=d3732e2994 href="http://www.ncbi.nlm.nih.gov/pubmed/28292437">PubMed Abstract </a> | <a target=xrefwindow id=d3732e2997 href="https://doi.org/10.1016/j.ccell.2017.02.005">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d3732e3007 class=n-a></a>Takahashi N, Chen HY, Harris IS, <i> et al.</i>: Cancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress Tolerance. <i>Cancer Cell.</i> 2018; <b>33</b>(6): 985–1003.e7. <a target=xrefwindow id=d3732e3018 href="http://www.ncbi.nlm.nih.gov/pubmed/29805077">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3021 href="https://doi.org/10.1016/j.ccell.2018.05.001">Publisher Full Text </a> | <a target=xrefwindow id=d3732e3025 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6100788">Free Full Text </a></span><div class=note><a name=d3732e3028 class=n-a></a><p class=first id=d3732e3029><a target=xrefwindow href="https://facultyopinions.com/prime/733287566" id=d3732e3030>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d3732e3039 class=n-a></a>Nilsson MB, Sun H, Diao L, <i> et al.</i>: Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockers. <i>Sci Transl Med.</i> 2017; <b>9</b>(415): eaao4307. <a target=xrefwindow id=d3732e3050 href="http://www.ncbi.nlm.nih.gov/pubmed/29118262">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3053 href="https://doi.org/10.1126/scitranslmed.aao4307">Publisher Full Text </a> | <a target=xrefwindow id=d3732e3057 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5870120">Free Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d3732e3066 class=n-a></a>Wang X, Prager BC, Wu Q, <i> et al.</i>: Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression. <i>Cell Stem Cell.</i> 2018; <b>22</b>(4): 514–528.e5. <a target=xrefwindow id=d3732e3077 href="http://www.ncbi.nlm.nih.gov/pubmed/29625067">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3080 href="https://doi.org/10.1016/j.stem.2018.03.011">Publisher Full Text </a> | <a target=xrefwindow id=d3732e3084 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5947947">Free Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d3732e3093 class=n-a></a>Yang H, Xia L, Chen J, <i> et al.</i>: Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity. <i>Nat Med.</i> 2019; <b>25</b>(9): 1428–41. <a target=xrefwindow id=d3732e3104 href="http://www.ncbi.nlm.nih.gov/pubmed/31501614">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3107 href="https://doi.org/10.1038/s41591-019-0566-4">Publisher Full Text </a></span><div class=note><a name=d3732e3110 class=n-a></a><p class=first id=d3732e3111><a target=xrefwindow href="https://facultyopinions.com/prime/736572075" id=d3732e3112>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d3732e3121 class=n-a></a>Rusan M, Li K, Li Y, <i> et al.</i>: Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression. <i>Cancer Discov.</i> 2018; <b>8</b>(1): 59–73. <a target=xrefwindow id=d3732e3132 href="http://www.ncbi.nlm.nih.gov/pubmed/29054992">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3135 href="https://doi.org/10.1158/2159-8290.CD-17-0461">Publisher Full Text </a> | <a target=xrefwindow id=d3732e3139 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5819998">Free Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d3732e3148 class=n-a></a>Wallner L, Dai J, Escara-Wilke J, <i> et al.</i>: Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice. <i>Cancer Res.</i> 2006; <b>66</b>(6): 3087–95. <a target=xrefwindow id=d3732e3159 href="http://www.ncbi.nlm.nih.gov/pubmed/16540658">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3162 href="https://doi.org/10.1158/0008-5472.CAN-05-3447">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d3732e3172 class=n-a></a>Straussman R, Morikawa T, Shee K, <i> et al.</i>: Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. <i>Nature.</i> 2012; <b>487</b>(7408): 500–4. <a target=xrefwindow id=d3732e3183 href="http://www.ncbi.nlm.nih.gov/pubmed/22763439">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3186 href="https://doi.org/10.1038/nature11183">Publisher Full Text </a> | <a target=xrefwindow id=d3732e3190 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3711467">Free Full Text </a></span><div class=note><a name=d3732e3193 class=n-a></a><p class=first id=d3732e3194><a target=xrefwindow href="https://facultyopinions.com/prime/717950217" id=d3732e3195>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d3732e3204 class=n-a></a>Roswall P, Bocci M, Bartoschek M, <i> et al.</i>: Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling. <i>Nat Med.</i> 2018; <b>24</b>(4): 463–73. <a target=xrefwindow id=d3732e3215 href="http://www.ncbi.nlm.nih.gov/pubmed/29529015">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3218 href="https://doi.org/10.1038/nm.4494">Publisher Full Text </a> | <a target=xrefwindow id=d3732e3222 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5896729">Free Full Text </a></span><div class=note><a name=d3732e3225 class=n-a></a><p class=first id=d3732e3226><a target=xrefwindow href="https://facultyopinions.com/prime/732830245" id=d3732e3227>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d3732e3236 class=n-a></a>Boshuizen J, Koopman LA, Krijgsman O, <i> et al.</i>: Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors. <i>Nat Med.</i> 2018; <b>24</b>(2): 203–12. <a target=xrefwindow id=d3732e3247 href="http://www.ncbi.nlm.nih.gov/pubmed/29334371">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3250 href="https://doi.org/10.1038/nm.4472">Publisher Full Text </a></span><div class=note><a name=d3732e3253 class=n-a></a><p class=first id=d3732e3254><a target=xrefwindow href="https://facultyopinions.com/prime/732463293" id=d3732e3255>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d3732e3264 class=n-a></a>Viswanathan VS, Ryan MJ, Dhruv HD, <i> et al.</i>: Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. <i>Nature.</i> 2017; <b>547</b>(7664): 453–7. <a target=xrefwindow id=d3732e3275 href="http://www.ncbi.nlm.nih.gov/pubmed/28678785">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3278 href="https://doi.org/10.1038/nature23007">Publisher Full Text </a> | <a target=xrefwindow id=d3732e3282 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5667900">Free Full Text </a></span><div class=note><a name=d3732e3285 class=n-a></a><p class=first id=d3732e3286><a target=xrefwindow href="https://facultyopinions.com/prime/727777471" id=d3732e3287>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d3732e3296 class=n-a></a>Hangauer MJ, Viswanathan VS, Ryan MJ, <i> et al.</i>: Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. <i>Nature.</i> 2017; <b>551</b>(7679): 247–50. <a target=xrefwindow id=d3732e3307 href="http://www.ncbi.nlm.nih.gov/pubmed/29088702">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3310 href="https://doi.org/10.1038/nature24297">Publisher Full Text </a> | <a target=xrefwindow id=d3732e3314 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5933935">Free Full Text </a></span><div class=note><a name=d3732e3317 class=n-a></a><p class=first id=d3732e3318><a target=xrefwindow href="https://facultyopinions.com/prime/732062541" id=d3732e3319>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d3732e3328 class=n-a></a>Tsoi J, Robert L, Paraiso K, <i> et al.</i>: Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress. <i>Cancer Cell.</i> 2018; <b>33</b>(5): 890–904.e5. <a target=xrefwindow id=d3732e3339 href="http://www.ncbi.nlm.nih.gov/pubmed/29657129">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3342 href="https://doi.org/10.1016/j.ccell.2018.03.017">Publisher Full Text </a> | <a target=xrefwindow id=d3732e3346 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5953834">Free Full Text </a></span><div class=note><a name=d3732e3349 class=n-a></a><p class=first id=d3732e3350><a target=xrefwindow href="https://facultyopinions.com/prime/733057547" id=d3732e3351>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d3732e3361 class=n-a></a>Das Thakur M, Salangsang F, Landman AS, <i> et al.</i>: Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance. <i>Nature.</i> 2013; <b>494</b>(7436): 251–5. <a target=xrefwindow id=d3732e3372 href="http://www.ncbi.nlm.nih.gov/pubmed/23302800">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3375 href="https://doi.org/10.1038/nature11814">Publisher Full Text </a> | <a target=xrefwindow id=d3732e3379 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3930354">Free Full Text </a></span><div class=note><a name=d3732e3382 class=n-a></a><p class=first id=d3732e3383><a target=xrefwindow href="https://facultyopinions.com/prime/717992185" id=d3732e3384>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d3732e3393 class=n-a></a>Pattabiraman DR, Bierie B, Kober KI, <i> et al.</i>: Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability. <i>Science.</i> 2016; <b>351</b>(6277): aad3680. <a target=xrefwindow id=d3732e3404 href="http://www.ncbi.nlm.nih.gov/pubmed/26941323">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3407 href="https://doi.org/10.1126/science.aad3680">Publisher Full Text </a> | <a target=xrefwindow id=d3732e3411 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5131720">Free Full Text </a></span><div class=note><a name=d3732e3414 class=n-a></a><p class=first id=d3732e3415><a target=xrefwindow href="https://facultyopinions.com/prime/726190235" id=d3732e3416>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d3732e3425 class=n-a></a>Ishay-Ronen D, Diepenbruck M, Kalathur RKR, <i> et al.</i>: Gain Fat-Lose Metastasis: Converting Invasive Breast Cancer Cells into Adipocytes Inhibits Cancer Metastasis. <i>Cancer Cell.</i> 2019; <b>35</b>(1): 17–32.e6. <a target=xrefwindow id=d3732e3436 href="http://www.ncbi.nlm.nih.gov/pubmed/30645973">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3439 href="https://doi.org/10.1016/j.ccell.2018.12.002">Publisher Full Text </a></span><div class=note><a name=d3732e3442 class=n-a></a><p class=first id=d3732e3443><a target=xrefwindow href="https://facultyopinions.com/prime/734856021" id=d3732e3444>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d3732e3453 class=n-a></a>Lu M, Jolly MK, Levine H, <i> et al.</i>: MicroRNA-based regulation of epithelial-hybrid-mesenchymal fate determination. <i>Proc Natl Acad Sci U S A.</i> 2013; <b>110</b>(45): 18144–9. <a target=xrefwindow id=d3732e3464 href="http://www.ncbi.nlm.nih.gov/pubmed/24154725">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3467 href="https://doi.org/10.1073/pnas.1318192110">Publisher Full Text </a> | <a target=xrefwindow id=d3732e3471 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3831488">Free Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d3732e3480 class=n-a></a>Jolly MK, Kulkarni P, Weninger K, <i> et al.</i>: Phenotypic Plasticity, Bet-Hedging, and Androgen Independence in Prostate Cancer: Role of Non-Genetic Heterogeneity. <i>Front Oncol.</i> 2018; <b>8</b>: 50. <a target=xrefwindow id=d3732e3491 href="http://www.ncbi.nlm.nih.gov/pubmed/29560343">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3494 href="https://doi.org/10.3389/fonc.2018.00050">Publisher Full Text </a> | <a target=xrefwindow id=d3732e3498 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5845637">Free Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d3732e3507 class=n-a></a>Bocci F, Jolly MK, George JT, <i> et al.</i>: A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signaling. <i>Oncotarget.</i> 2018; <b>9</b>(52): 29906–29920. <a target=xrefwindow id=d3732e3518 href="http://www.ncbi.nlm.nih.gov/pubmed/30042822">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3521 href="https://doi.org/10.18632/oncotarget.25692">Publisher Full Text </a> | <a target=xrefwindow id=d3732e3525 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6057462">Free Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d3732e3535 class=n-a></a>Jia D, George JT, Tripathi SC, <i> et al.</i>: Testing the gene expression classification of the EMT spectrum. <i>Phys Biol.</i> 2019; <b>16</b>(2): 25002. <a target=xrefwindow id=d3732e3546 href="http://www.ncbi.nlm.nih.gov/pubmed/30557866">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3549 href="https://doi.org/10.1088/1478-3975/aaf8d4">Publisher Full Text </a> | <a target=xrefwindow id=d3732e3553 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7179477">Free Full Text </a></span><div class=note><a name=d3732e3555 class=n-a></a><p class=first id=d3732e3556><a target=xrefwindow href="https://facultyopinions.com/prime/735228802" id=d3732e3557>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d3732e3566 class=n-a></a>Kröger C, Afeyan A, Mraz J, <i> et al.</i>: Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells. <i>Proc Natl Acad Sci U S A.</i> 2019; <b>116</b>(15): 7353–62. <a target=xrefwindow id=d3732e3577 href="http://www.ncbi.nlm.nih.gov/pubmed/30910979">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3580 href="https://doi.org/10.1073/pnas.1812876116">Publisher Full Text </a> | <a target=xrefwindow id=d3732e3584 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6462070">Free Full Text </a></span><div class=note><a name=d3732e3586 class=n-a></a><p class=first id=d3732e3587><a target=xrefwindow href="https://facultyopinions.com/prime/735395410" id=d3732e3588>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d3732e3597 class=n-a></a>Bocci F, Levine H, Onuchic JN, <i> et al.</i>: Deciphering the Dynamics of Epithelial-Mesenchymal Transition and Cancer Stem Cells in Tumor Progression. <i>Curr Stem Cell Rep.</i> 2019; <b>5</b>: 11–21. <a target=xrefwindow id=d3732e3608 href="https://doi.org/10.1007/s40778-019-0150-3">Publisher Full Text </a></span><div class=note><a name=d3732e3610 class=n-a></a><p class=first id=d3732e3611><a target=xrefwindow href="https://facultyopinions.com/prime/735869199" id=d3732e3612>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d3732e3621 class=n-a></a>Tian XJ, Zhang H, Xing J: Coupled reversible and irreversible bistable switches underlying TGFβ-induced epithelial to mesenchymal transition. <i>Biophys J.</i> 2013; <b>105</b>(4): 1079–89. <a target=xrefwindow id=d3732e3629 href="http://www.ncbi.nlm.nih.gov/pubmed/23972859">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3632 href="https://doi.org/10.1016/j.bpj.2013.07.011">Publisher Full Text </a> | <a target=xrefwindow id=d3732e3635 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3752104">Free Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d3732e3644 class=n-a></a>Carrère C: Optimization of an <i>in vitro</i> chemotherapy to avoid resistant tumours. <i>J Theor Biol.</i> 2017; <b>413</b>: 24–33. <a target=xrefwindow id=d3732e3655 href="http://www.ncbi.nlm.nih.gov/pubmed/27864095">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3658 href="https://doi.org/10.1016/j.jtbi.2016.11.009">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d3732e3667 class=n-a></a>Pisco AO, Brock A, Zhou J, <i> et al.</i>: Non-Darwinian dynamics in therapy-induced cancer drug resistance. <i>Nat Commun.</i> 2013; <b>4</b>: 2467. <a target=xrefwindow id=d3732e3678 href="http://www.ncbi.nlm.nih.gov/pubmed/24045430">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3681 href="https://doi.org/10.1038/ncomms3467">Publisher Full Text </a> | <a target=xrefwindow id=d3732e3685 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4657953">Free Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d3732e3695 class=n-a></a>Pisco AO, Huang S: Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: 'What does not kill me strengthens me'. <i>Br J Cancer.</i> 2015; <b>112</b>(11): 1725–32. <a target=xrefwindow id=d3732e3703 href="http://www.ncbi.nlm.nih.gov/pubmed/25965164">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3706 href="https://doi.org/10.1038/bjc.2015.146">Publisher Full Text </a> | <a target=xrefwindow id=d3732e3709 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4647245">Free Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d3732e3718 class=n-a></a>Lorz A, Lorenzi T, Clairambault J, <i> et al.</i>: Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors. <i>Bull Math Biol.</i> 2015; <b>77</b>(1): 1–22. <a target=xrefwindow id=d3732e3729 href="http://www.ncbi.nlm.nih.gov/pubmed/25480478">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3732 href="https://doi.org/10.1007/s11538-014-0046-4">Publisher Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d3732e3741 class=n-a></a>Lorenzi T, Chisholm RH, Clairambault J: Tracking the evolution of cancer cell populations through the mathematical lens of phenotype-structured equations. <i>Biol Direct.</i> 2016; <b>11</b>(1): 43. <a target=xrefwindow id=d3732e3749 href="http://www.ncbi.nlm.nih.gov/pubmed/27550042">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3752 href="https://doi.org/10.1186/s13062-016-0143-4">Publisher Full Text </a> | <a target=xrefwindow id=d3732e3755 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4994266">Free Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d3732e3764 class=n-a></a>Pouchol C, Clairambault J, Lorz A, <i> et al.</i>: Asymptotic analysis and optimal control of an integro-differential system modelling healthy and cancer cells exposed to chemotherapy. <i>Journal de Mathématiques Pures et Appliquées.</i> 2018; <b>116</b>: 268–308. <a target=xrefwindow id=d3732e3775 href="https://doi.org/10.1016/j.matpur.2017.10.007">Publisher Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d3732e3784 class=n-a></a>Almeida L, Bagnerini P, Fabrini G, <i> et al.</i>: Evolution of cancer cell populations under cytotoxic therapy and treatment optimisation: Insight from a phenotype-structured model. <i>ESAIM: M2AN.</i> 2019; <b>53</b>(4): 1157–90. <a target=xrefwindow id=d3732e3795 href="https://doi.org/10.1051/M2AN/2019010">Publisher Full Text </a></span><div class=note><a name=d3732e3797 class=n-a></a><p class=first id=d3732e3798><a target=xrefwindow href="https://facultyopinions.com/prime/736098005" id=d3732e3799>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d3732e3808 class=n-a></a>Nguyen TN, Clairambault J, Jaffredo T, <i> et al.</i>: Adaptive dynamics of hematopoietic stem cells and their supporting stroma: A model and mathematical analysis. <i>Math Biosci Eng.</i> 2019; <b>16</b>(5): 4818–45. <a target=xrefwindow id=d3732e3819 href="http://www.ncbi.nlm.nih.gov/pubmed/31499692">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3822 href="https://doi.org/10.3934/mbe.2019243">Publisher Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d3732e3832 class=n-a></a>Clairambault J: An Evolutionary Perspective on Cancer, with Applications to Anticancer Drug Resistance Modelling and Perspectives in Therapeutic Control. <i>JMS.</i> 2019; <b>52</b>(4): 470–96. <a target=xrefwindow id=d3732e3840 href="https://doi.org/10.4208/jms.v52n4.19.06">Publisher Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d3732e3849 class=n-a></a>Clairambault J, Pouchol C: A survey of adaptive cell population dynamics models of emergence of drug resistance in cancer, and open questions about evolution and cancer. <i>BIOMATH.</i> 2019; <b>8</b>(1): 1905147. <a target=xrefwindow id=d3732e3857 href="https://doi.org/10.11145/j.biomath.2019.05.147">Publisher Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d3732e3866 class=n-a></a>Stace REA, Stiehl T, Chaplain MAJ, <i> et al.</i>: Discrete and continuum phenotype-structured models for the evolution of cancer cell populations under chemotherapy. <i>Math Model Nat Phenom.</i> 2020; <b>15</b>: 14. <a target=xrefwindow id=d3732e3877 href="https://doi.org/10.1051/mmnp/2019027">Publisher Full Text </a></span><div class=note><a name=d3732e3879 class=n-a></a><p class=first id=d3732e3881><a target=xrefwindow href="https://facultyopinions.com/prime/738105068" id=d3732e3882>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d3732e3891 class=n-a></a>Zhu XM, Yin L, Hood L, <i> et al.</i>: Robustness, stability and efficiency of phage lambda genetic switch: Dynamical structure analysis. <i>J Bioinform Comput Biol.</i> 2004; <b>2</b>(4): 785–817. <a target=xrefwindow id=d3732e3902 href="http://www.ncbi.nlm.nih.gov/pubmed/15617166">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3905 href="https://doi.org/10.1142/s0219720004000946">Publisher Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d3732e3914 class=n-a></a>Su H, Wang G, Yuan R, <i> et al.</i>: Decoding early myelopoiesis from dynamics of core endogenous network. <i>Sci China Life Sci.</i> 2017; <b>60</b>(6): 627–46. <a target=xrefwindow id=d3732e3925 href="http://www.ncbi.nlm.nih.gov/pubmed/28646471">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3928 href="https://doi.org/10.1007/s11427-017-9059-y">Publisher Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d3732e3937 class=n-a></a>Yuan R, Zhu X, Wang G, <i> et al.</i>: Cancer as robust intrinsic state shaped by evolution: A key issues review. <i>Rep Prog Phys.</i> 2017; <b>80</b>(4): 42701. <a target=xrefwindow id=d3732e3948 href="http://www.ncbi.nlm.nih.gov/pubmed/28212112">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3951 href="https://doi.org/10.1088/1361-6633/aa538e">Publisher Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d3732e3961 class=n-a></a>Ao P, Galas D, Hood L, <i> et al.</i>: Cancer as robust intrinsic state of endogenous molecular-cellular network shaped by evolution. <i>Medical Hypotheses.</i> 2008; <b>70</b>(3): 678–84. <a target=xrefwindow id=d3732e3972 href="http://www.ncbi.nlm.nih.gov/pubmed/17766049">PubMed Abstract </a> | <a target=xrefwindow id=d3732e3975 href="https://doi.org/10.1016/j.mehy.2007.03.043">Publisher Full Text </a> | <a target=xrefwindow id=d3732e3979 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3166219">Free Full Text </a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d3732e3988 class=n-a></a>Wang G, Su H, Yu H, <i> et al.</i>: Endogenous network states predict gain or loss of functions for genetic mutations in hepatocellular carcinoma. <i>J R Soc Interface.</i> 2016; <b>13</b>(115): 20151115. <a target=xrefwindow id=d3732e3999 href="http://www.ncbi.nlm.nih.gov/pubmed/26911487">PubMed Abstract </a> | <a target=xrefwindow id=d3732e4002 href="https://doi.org/10.1098/rsif.2015.1115">Publisher Full Text </a> | <a target=xrefwindow id=d3732e4006 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4780567">Free Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a name=d3732e4015 class=n-a></a>Ao P: Global view of bionetwork dynamics: Adaptive landscape. <i>J Genet Genomics.</i> 2009; <b>36</b>(2): 63–73. <a target=xrefwindow id=d3732e4023 href="http://www.ncbi.nlm.nih.gov/pubmed/19232305">PubMed Abstract </a> | <a target=xrefwindow id=d3732e4026 href="https://doi.org/10.1016/S1673-8527(08)60093-4">Publisher Full Text </a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d3732e4035 class=n-a></a>Robertson-Tessi M, Gillies RJ, Gatenby RA, <i> et al.</i>: Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes. <i>Cancer Res.</i> 2015; <b>75</b>(8): 1567–79. <a target=xrefwindow id=d3732e4046 href="http://www.ncbi.nlm.nih.gov/pubmed/25878146">PubMed Abstract </a> | <a target=xrefwindow id=d3732e4049 href="https://doi.org/10.1158/0008-5472.CAN-14-1428">Publisher Full Text </a> | <a target=xrefwindow id=d3732e4053 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4421891">Free Full Text </a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a name=d3732e4062 class=n-a></a>Soto A, Sonnenschein C: The society of cells. Bios Sciences Publ. 1999;. <a target=xrefwindow id=d3732e4064 href="https://books.google.co.in/books?id=DPZqAAAAMAAJ&amp;q=The+Society+of+Cells+Cancer+and+Control+of+Cell+Proliferation+pdf&amp;dq=The+Society+of+Cells+Cancer+and+Control+of+Cell+Proliferation+pdf&amp;hl=en&amp;sa=X&amp;ved=0ahUKEwifpqWOi_7pAhUjzTgGHVaxC0UQ6AEIJzAA">Reference Source</a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a name=d3732e4073 class=n-a></a>Soto AM, Sonnenschein C: The somatic mutation theory of cancer: Growing problems with the paradigm? <i>Bioessays.</i> 2004; <b>26</b>(10): 1097–107. <a target=xrefwindow id=d3732e4081 href="http://www.ncbi.nlm.nih.gov/pubmed/15382143">PubMed Abstract </a> | <a target=xrefwindow id=d3732e4084 href="https://doi.org/10.1002/bies.20087">Publisher Full Text </a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a name=d3732e4094 class=n-a></a>Sonnenschein C, Soto AM, <i> et al.</i>: Carcinogenesis explained within the context of a theory of organisms. <i>Prog Biophys Mol Biol.</i> 2016; <b>122</b>(1): 70–6. <a target=xrefwindow id=d3732e4105 href="http://www.ncbi.nlm.nih.gov/pubmed/27498170">PubMed Abstract </a> | <a target=xrefwindow id=d3732e4108 href="https://doi.org/10.1016/j.pbiomolbio.2016.07.004">Publisher Full Text </a> | <a target=xrefwindow id=d3732e4112 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5501415">Free Full Text </a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a name=d3732e4121 class=n-a></a>Huang S: Genetic and non-genetic instability in tumor progression: Link between the fitness landscape and the epigenetic landscape of cancer cells. <i>Cancer Metastasis Rev.</i> 2013; <b>32</b>(3–4): 423–48. <a target=xrefwindow id=d3732e4129 href="http://www.ncbi.nlm.nih.gov/pubmed/23640024">PubMed Abstract </a> | <a target=xrefwindow id=d3732e4132 href="https://doi.org/10.1007/s10555-013-9435-7">Publisher Full Text </a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a name=d3732e4141 class=n-a></a>Huang S, Guo YP, May G, <i> et al.</i>: Bifurcation dynamics in lineage-commitment in bipotent progenitor cells. <i>Dev Biol.</i> 2007; <b>305</b>(2): 695–713. <a target=xrefwindow id=d3732e4152 href="http://www.ncbi.nlm.nih.gov/pubmed/17412320">PubMed Abstract </a> | <a target=xrefwindow id=d3732e4155 href="https://doi.org/10.1016/j.ydbio.2007.02.036">Publisher Full Text </a></span><div class=note><a name=d3732e4157 class=n-a></a><p class=first id=d3732e4158><a target=xrefwindow href="https://facultyopinions.com/prime/1121852" id=d3732e4159>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a name=d3732e4168 class=n-a></a>Vincent M: Cancer: A de-repression of a default survival program common to all cells?: a life-history perspective on the nature of cancer. <i>Bioessays.</i> 2012; <b>34</b>(1): 72–82. <a target=xrefwindow id=d3732e4176 href="http://www.ncbi.nlm.nih.gov/pubmed/22105565">PubMed Abstract </a> | <a target=xrefwindow id=d3732e4179 href="https://doi.org/10.1002/bies.201100049">Publisher Full Text </a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a name=d3732e4188 class=n-a></a>Davies PCW, Lineweaver CH: Cancer tumors as Metazoa 1.0: Tapping genes of ancient ancestors. <i>Phys Biol.</i> 2011; <b>8</b>(1): 15001. <a target=xrefwindow id=d3732e4196 href="http://www.ncbi.nlm.nih.gov/pubmed/21301065">PubMed Abstract </a> | <a target=xrefwindow id=d3732e4199 href="https://doi.org/10.1088/1478-3975/8/1/015001">Publisher Full Text </a> | <a target=xrefwindow id=d3732e4202 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3148211">Free Full Text </a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a name=d3732e4211 class=n-a></a>Israel L: Tumour progression: Random mutations or an integrated survival response to cellular stress conserved from unicellular organisms? <i>J Theor Biol.</i> 1996; <b>178</b>(4): 375–80. <a target=xrefwindow id=d3732e4219 href="http://www.ncbi.nlm.nih.gov/pubmed/8733476">PubMed Abstract </a> | <a target=xrefwindow id=d3732e4222 href="https://doi.org/10.1006/jtbi.1996.0033">Publisher Full Text </a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a name=d3732e4232 class=n-a></a>Domazet-Loso T, Tautz D: An ancient evolutionary origin of genes associated with human genetic diseases. <i>Mol Biol Evol.</i> 2008; <b>25</b>(12): 2699–707. <a target=xrefwindow id=d3732e4240 href="http://www.ncbi.nlm.nih.gov/pubmed/18820252">PubMed Abstract </a> | <a target=xrefwindow id=d3732e4243 href="https://doi.org/10.1093/molbev/msn214">Publisher Full Text </a> | <a target=xrefwindow id=d3732e4246 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2582983">Free Full Text </a></span><div class=note><a name=d3732e4249 class=n-a></a><p class=first id=d3732e4250><a target=xrefwindow href="https://facultyopinions.com/prime/1138977" id=d3732e4251>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a name=d3732e4260 class=n-a></a>Domazet-Lošo T, Tautz D: Phylostratigraphic tracking of cancer genes suggests a link to the emergence of multicellularity in metazoa. <i>BMC Biol.</i> 2010; <b>8</b>: 66. <a target=xrefwindow id=d3732e4268 href="http://www.ncbi.nlm.nih.gov/pubmed/20492640">PubMed Abstract </a> | <a target=xrefwindow id=d3732e4271 href="https://doi.org/10.1186/1741-7007-8-66">Publisher Full Text </a> | <a target=xrefwindow id=d3732e4274 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2880965">Free Full Text </a></span><div class=note><a name=d3732e4276 class=n-a></a><p class=first id=d3732e4277><a target=xrefwindow href="https://facultyopinions.com/prime/4160956" id=d3732e4278>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a name=d3732e4287 class=n-a></a>Cisneros L, Bussey KJ, Orr AJ, <i> et al.</i>: Ancient genes establish stress-induced mutation as a hallmark of cancer. <i>PLoS One.</i> 2017; <b>12</b>(4): e0176258. <a target=xrefwindow id=d3732e4298 href="http://www.ncbi.nlm.nih.gov/pubmed/28441401">PubMed Abstract </a> | <a target=xrefwindow id=d3732e4301 href="https://doi.org/10.1371/journal.pone.0176258">Publisher Full Text </a> | <a target=xrefwindow id=d3732e4305 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5404761">Free Full Text </a></span></li><li><a name=ref-117 class=n-a></a><span class=label>117. </span>&nbsp;<span class=citation><a name=d3732e4314 class=n-a></a>Trigos AS, Pearson RB, Papenfuss AT, <i> et al.</i>: Altered interactions between unicellular and multicellular genes drive hallmarks of transformation in a diverse range of solid tumors. <i>Proc Natl Acad Sci U S A.</i> 2017; <b>114</b>(24): 6406–11. <a target=xrefwindow id=d3732e4325 href="http://www.ncbi.nlm.nih.gov/pubmed/28484005">PubMed Abstract </a> | <a target=xrefwindow id=d3732e4328 href="https://doi.org/10.1073/pnas.1617743114">Publisher Full Text </a> | <a target=xrefwindow id=d3732e4332 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5474804">Free Full Text </a></span></li><li><a name=ref-118 class=n-a></a><span class=label>118. </span>&nbsp;<span class=citation><a name=d3732e4341 class=n-a></a>Trigos AS, Pearson RB, Papenfuss AT, <i> et al.</i>: How the evolution of multicellularity set the stage for cancer. <i>Br J Cancer.</i> 2018; <b>118</b>(12): 145–52. <a target=xrefwindow id=d3732e4352 href="http://www.ncbi.nlm.nih.gov/pubmed/29337961">PubMed Abstract </a> | <a target=xrefwindow id=d3732e4355 href="https://doi.org/10.1038/bjc.2017.398">Publisher Full Text </a> | <a target=xrefwindow id=d3732e4359 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5785747">Free Full Text </a></span><div class=note><a name=d3732e4362 class=n-a></a><p class=first id=d3732e4363><a target=xrefwindow href="https://facultyopinions.com/prime/732499701" id=d3732e4364>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-119 class=n-a></a><span class=label>119. </span>&nbsp;<span class=citation><a name=d3732e4373 class=n-a></a>Trigos AS, Pearson RB, Papenfuss AT, <i> et al.</i>: Somatic mutations in early metazoan genes disrupt regulatory links between unicellular and multicellular genes in cancer. <i>eLife.</i> 2019; <b>8</b>: e40947. <a target=xrefwindow id=d3732e4384 href="http://www.ncbi.nlm.nih.gov/pubmed/30803482">PubMed Abstract </a> | <a target=xrefwindow id=d3732e4387 href="https://doi.org/10.7554/eLife.40947">Publisher Full Text </a> | <a target=xrefwindow id=d3732e4391 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6402835">Free Full Text </a></span><div class=note><a name=d3732e4393 class=n-a></a><p class=first id=d3732e4394><a target=xrefwindow href="https://facultyopinions.com/prime/735161470" id=d3732e4395>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-120 class=n-a></a><span class=label>120. </span>&nbsp;<span class=citation><a name=d3732e4405 class=n-a></a>Chisholm RH, Lorenzi T, Clairambault J: Cell population heterogeneity and evolution towards drug resistance in cancer: Biological and mathematical assessment, theoretical treatment optimisation. <i>Biochim Biophys Acta.</i> 2016; <b>1860</b>(11 Pt B): 2627–45. <a target=xrefwindow id=d3732e4413 href="http://www.ncbi.nlm.nih.gov/pubmed/27339473">PubMed Abstract </a> | <a target=xrefwindow id=d3732e4416 href="https://doi.org/10.1016/j.bbagen.2016.06.009">Publisher Full Text </a></span></li><li><a name=ref-121 class=n-a></a><span class=label>121. </span>&nbsp;<span class=citation><a name=d3732e4425 class=n-a></a>Goldman A, Kohandel M, Clairambault J: Integrating Biological and Mathematical Models to Explain and Overcome Drug Resistance in Cancer. Part 1: Biological Facts and Studies in Drug Resistance. <i>Curr Stem Cell Rep.</i> 2017; <b>3</b>: 253–9. <a target=xrefwindow id=d3732e4433 href="https://doi.org/10.1007/s40778-017-0097-1">Publisher Full Text </a></span></li><li><a name=ref-122 class=n-a></a><span class=label>122. </span>&nbsp;<span class=citation><a name=d3732e4442 class=n-a></a>Goldman A, Kohandel M, Clairambault J: Integrating Biological and Mathematical Models to Explain and Overcome Drug Resistance in Cancer, Part 2: From Theoretical Biology to Mathematical Models. <i>Curr Stem Cell Rep.</i> 2017; <b>3</b>: 260–8. <a target=xrefwindow id=d3732e4450 href="https://doi.org/10.1007/s40778-017-0098-0">Publisher Full Text </a></span></li><li><a name=ref-123 class=n-a></a><span class=label>123. </span>&nbsp;<span class=citation><a name=d3732e4459 class=n-a></a>Moya F: Epistemology of living organisms in Aristotle’s philosophy. <i>Theory Biosci.</i> 2000; <b>119</b>: 318–33. <a target=xrefwindow id=d3732e4467 href="https://doi.org/10.1007/s12064-000-0020-6">Publisher Full Text </a></span></li><li><a name=ref-124 class=n-a></a><span class=label>124. </span>&nbsp;<span class=citation><a name=d3732e4476 class=n-a></a>Pradeu T: The limits of the self. Oxford University Press, 2012. <a target=xrefwindow id=d3732e4478 href="https://global.oup.com/academic/product/the-limits-of-the-self-9780199775286?cc=id&amp;lang=en&amp;#">Reference Source</a></span></li><li><a name=ref-125 class=n-a></a><span class=label>125. </span>&nbsp;<span class=citation><a name=d3732e4487 class=n-a></a>Pradeu T: Philosophy of immunology. Cambridge University Press, 2019. <a target=xrefwindow id=d3732e4489 href="https://www.cambridge.org/core/elements/philosophy-of-immunology/06F0C341035299674EECF0406E5D8E31">Reference Source</a></span></li><li><a name=ref-126 class=n-a></a><span class=label>126. </span>&nbsp;<span class=citation><a name=d3732e4499 class=n-a></a>Müller WEG: Review: How was metazoan threshold crossed? The hypothetical Urmetazoa. <i> Comp Biochem Physiol A Mol Integr Physiol.</i> 2001; <b>129</b>(2–3): 433–60. <a target=xrefwindow id=d3732e4507 href="http://www.ncbi.nlm.nih.gov/pubmed/11423315">PubMed Abstract </a> | <a target=xrefwindow id=d3732e4510 href="https://doi.org/10.1016/S1095-6433(00)00360-3">Publisher Full Text </a></span></li><li><a name=ref-127 class=n-a></a><span class=label>127. </span>&nbsp;<span class=citation><a name=d3732e4519 class=n-a></a>Müller WEG, Müller IM: Origin of the metazoan immune system: Identification of the molecules and their functions in sponges. <i>Integr Comp Biol.</i> 2003; <b>43</b>(2): 281–92. <a target=xrefwindow id=d3732e4527 href="http://www.ncbi.nlm.nih.gov/pubmed/21680435">PubMed Abstract </a> | <a target=xrefwindow id=d3732e4530 href="https://doi.org/10.1093/icb/43.2.281">Publisher Full Text </a></span></li><li><a name=ref-128 class=n-a></a><span class=label>128. </span>&nbsp;<span class=citation><a name=d3732e4539 class=n-a></a>Laplane L: Cancer stem cells. Harvard University Press, 2016. <a target=xrefwindow id=d3732e4541 href="https://www.hup.harvard.edu/catalog.php?isbn=9780674088740">Reference Source</a></span></li><li><a name=ref-129 class=n-a></a><span class=label>129. </span>&nbsp;<span class=citation><a name=d3732e4550 class=n-a></a>Bertolaso M: Philosophy of Cancer A Dynamic and Relational View. Springer Publ. 2018. <a target=xrefwindow id=d3732e4552 href="https://doi.org/10.1007/978-94-024-0865-2">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 22 Jun 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-635.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-635.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Inserm U981, Institut Gustave Roussy, Universit&eacute; Paris-Saclay, Villejuif, France<br/> <sup>2</sup> Sorbonne Universit&eacute;, CNRS, Universit&eacute; de Paris, Laboratoire Jacques&shy;Louis Lions (LJLL), &amp; Inria Mamba team, Paris, France<br/> <p> <div class=margin-bottom> Shensi Shen <br/> <span>Roles: </span> Conceptualization, Investigation, Methodology, Project Administration, Writing – Original Draft Preparation </div> <div class=margin-bottom> Jean Clairambault <br/> <span>Roles: </span> Conceptualization, Investigation, Methodology, Project Administration, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/9-635/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 22 Jun 2020, 9:635 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.24803.1">https://doi.org/10.12688/f1000research.24803.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2020 Shen S and Clairambault J. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=27365 data-id=24803 data-downloads="" data-views="" data-scholar="10.12688/f1000research.24803.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/9-635/v1/pdf?article_uuid=0521f1ca-5106-433e-968d-3ed0c230b29e" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.24803.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Shen S and Clairambault J. Cell plasticity in cancer cell populations [version 1; peer review: 2 approved] <i>F1000Research</i> 2020, <b>9</b>(F1000 Faculty Rev):635 (<a href="https://doi.org/10.12688/f1000research.24803.1" target=_blank>https://doi.org/10.12688/f1000research.24803.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=24803 id=mobile-track-article-signin-24803 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/24803?target=/articles/9-635.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=27365 /> <input name=articleId type=hidden value=24803 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Ping Ao</strong>, Shanghai Center for Quantitative Life Sciences, Shanghai University, China </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>G&aacute;bor Bal&aacute;zsi</strong>, The Louis and Beatrice Laufer Center for Physical and Quantitative Biology, Stony Brook University, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 22 Jun 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-635.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-635.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=69838-65179></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=11564-65180></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/9-635/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>22 Jun 20</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Ping Ao</strong>, Shanghai Center for Quantitative Life Sciences, Shanghai University, China </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>G&aacute;bor Bal&aacute;zsi</strong>, The Louis and Beatrice Laufer Center for Physical and Quantitative Biology, Stony Brook University, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/9-635.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/9-635/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Cell plasticity in cancer cell populations".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/9-635/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/9-635/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/9-635/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Shen S and Clairambault J');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/9-635/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/9-635",
            templates : {
                twitter : "Cell plasticity in cancer cell populations. Shen S and Clairambault J, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/9-635/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Cell plasticity in cancer cell populations", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Cell plasticity in cancer cell populations", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/24803/27365")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "27365");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "65179": 0,
                           "65180": 1,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "4e2d0917-09a0-4931-83eb-f94dc6365ab0";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-635.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-635.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-635.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/9-635.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/9-635.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>